Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3007844	s-ebvabm	— (—)	9206	11781	100.00%	Distribution not available
3007844	s-ebvabm	u/ml (—)	139	149	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cytomegalovirus infection, IBD co-morbidity

258

158

23.96

322.10

1.6

1.4

—

Cytomegaloviral disease

259

162

22.97

319.29

1.6

1.3

—

Used for control exclusion in common control thyroid runs

2495

5175

2.49

318.71

1.3

—

Other disorders of kidney and ureter

483

731

7.20

308.14

1.8

1.2

—

Deposits [accretions] on teeth

470

557

9.52

307.65

2.4

1.2

—

Anaemias

996

1117

6.30

307.65

1.6

1.2

—

Nephropathy related operations

1468

738

28.09

307.65

1.9

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3274

4667

4.11

307.65

1.5

1.1

—

Acute renal failure

642

906

7.57

307.65

1.5

1.1

—

Glomerular disorders in diseases classified elsewhere

703

709

11.51

307.65

1.7

1.2

—

Disorders resulting from impaired renal tubular function

367

229

22.31

307.65

1.9

1.2

—

Dental caries

1134

1929

6.29

307.65

1.8

1.2

—

ILD medications: azathioprine

717

994

7.92

307.65

1.8

1.1

—

Autoimmune diseases excluding thyroid diseases

2616

5381

2.76

307.65

1.3

—

Bacterial Sepsis

1036

2173

4.40

307.65

1.4

1.2

—

GASTRO-related operations

2363

2904

4.21

307.65

1.4

1.1

—

ILD medications

3556

4907

4.12

307.65

1.5

1.1

—

Septicaemia

1085

2151

5.07

307.65

1.6

1.3

—

Glomerular diseases

938

1206

8.72

307.65

1.9

1.2

—

Second line medication for Crohn's disease

1550

4790

3.36

307.65

1.5

1.2

—

Inflammatory bowel disease treatment related agents

2987

5808

3.00

307.65

1.3

1.2

—

Any gastric operation

2363

2904

4.21

307.65

1.4

1.1

—

Secondary hypertension

600

419

16.89

307.65

1.9

1.2

—

Fever of other and unknown origin

2182

3378

6.36

307.65

1.4

1.2

—

Persons encountering health services for specific procedures and health care

2841

5924

3.06

307.65

1.5

1.2

—

Preparatory care for dialysis

545

243

34.79

307.65

1.6

1.2

—

Other dialysis

442

223

33.39

307.65

2.0

1.4

—

Noninfective enteritis and colitis

1335

4120

3.36

307.65

1.3

—

Extracorporeal dialysis

778

379

31.27

307.65

1.9

1.2

—

Donors of organs and tissues

236

50.81

307.65

1.9

1.1

—

Care involving dialysis

1104

429

39.65

307.65

1.9

1.2

—

Autoimmune diseases related-to ILD

2043

6486

2.84

307.65

1.2

1.3

—

ILD medications: immunosuppressive drugs

2729

3994

7.02

307.65

1.6

1.2

—

Transplanted organ and tissue status

1639

614

45.64

307.65

1.9

1.1

—

Heart failure, not strict

1941

3198

4.35

307.65

1.5

1.2

—

Implicit bacterial Sepsis

906

1772

4.87

307.65

1.4

1.2

—

Diseases of liver

1200

2199

5.83

307.65

1.2

—

Dialysis, with operation codes

1470

714

28.48

307.65

1.8

1.2

—

General symptoms and signs

2824

4560

3.18

307.65

1.3

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2605

5474

3.52

307.65

1.4

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

2569

5273

2.78

307.65

1.3

—

Other bacterial diseases

2396

4983

3.43

307.65

1.4

1.2

—

Aplastic and other anaemias

1005

2409

4.10

307.65

1.5

1.2

—

Implicit Sepsis

1553

3952

3.14

307.65

1.4

1.2

—

Chronic periapical parodontitis

676

1243

5.78

307.65

1.4

1.2

—

Oral corticosteroids

2419

5394

2.78

307.65

1.2

—

Autoimmune diseases

2598

5453

2.48

307.65

1.3

—

Chronic periodontitis

580

764

8.26

307.65

1.5

1.1

—

Azathioprine

717

1146

6.86

307.65

1.8

1.3

—

L04AA Selective immunosuppressants

1384

1615

9.85

307.65

1.7

1.2

—

Chronic kidney disease

1505

1282

13.06

307.65

1.8

1.2

—

L04AX Other immunosuppressants

1432

4656

3.18

307.65

1.5

1.2

—

Dentinal caries

968

1675

6.20

307.65

1.6

1.2

—

Kidney transplant status

975

390

49.53

307.65

2.1

1.3

—

Certain infectious and parasitic diseases

2238

4129

2.77

307.65

1.3

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

1056

1252

9.28

307.65

1.4

1.3

—

Inflammatory bowel disease

1058

2840

3.92

307.65

1.2

1.3

—

Renal failure

1769

1935

9.05

307.65

1.7

1.2

—

Dialysis

583

268

35.18

307.65

2.1

1.3

—

Explicit Sepsis

1136

2524

4.50

307.65

1.6

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2539

5450

3.26

307.65

1.6

1.1

—

Other septicaemia

988

1899

5.35

307.65

1.6

1.3

—

Renal tubulo-interstitial diseases

2303

5186

3.52

307.65

1.6

1.2

—

Inflammatory bowel disease, strict (require KELA)

894

2175

4.38

307.65

1.2

1.3

—

L04AD Calcineurin inhibitors

1455

806

26.91

307.65

1.9

1.2

—

Bacterial infection, other or unspecified

1536

2644

5.50

307.65

1.4

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

1056

1282

9.06

307.65

1.4

1.3

—

Enlarged lymph nodes

577

951

6.49

307.65

1.3

1.2

—

First line medication for Crohn's disease

3348

4864

3.88

307.65

1.4

1.2

—

IBD patients in KELA-register

894

2128

4.48

307.65

1.2

1.3

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

464

588

8.54

307.65

1.3

1.2

—

Other/unspecified cytomegaloviral diseases

236

134

27.10

306.86

1.6

1.4

—

Failure and rejection of transplanted organs and tissues

213

107

36.01

296.39

2.0

1.4

—

Diseases of pulp and periapical tissues

911

2455

3.86

291.83

1.4

1.2

—

Other diseases of blood and blood-forming organs, wide

671

1468

4.84

285.87

1.3

1.2

—

5-aminosalicylic acid

720

1668

4.56

285.14

1.2

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1717

4722

2.70

284.61

1.4

1.2

—

Malaise and fatigue

986

2318

3.64

279.21

1.2

—

Hypertensive diseases (excluding secondary)

1337

2500

3.20

276.38

1.6

1.2

—

Infections, IBD-co-morbidities

577

745

5.95

275.35

1.5

1.2

—

Viral Sepsis

565

1118

5.34

270.84

1.6

1.2

—

Cystic kidney disease

270

240

14.27

268.58

1.8

1.3

—

Implicit viral Sepsis

561

1117

5.31

267.01

1.6

1.2

—

Other viral diseases

1006

3110

3.39

261.32

1.5

1.3

—

Gastrointestinal diseases

1459

2520

2.96

254.88

1.4

1.2

—

Any reimbursement code in KELA

1510

2677

2.89

252.74

1.4

1.1

—

Direct fill therapy

570

1218

5.09

252.02

1.7

1.3

—

Unspecified kidney failure

312

360

9.33

250.71

1.7

1.1

—

Non-follicular lymphoma, hilmo, excluding all cancers

332

416

8.69

250.21

1.3

1.2

—

Other and unspecified anaemias

814

2178

3.73

248.08

1.4

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1844

4764

2.47

247.06

1.4

1.2

—

1844

4764

2.47

247.06

1.4

1.2

—

Other anaemias

817

2202

3.69

245.15

1.4

1.2

—

Diabetic nephropathy

484

905

5.67

243.76

1.7

1.2

—

Myeloid leukaemia

201

128

19.80

241.82

1.4

1.2

—

Diabetic nephropathy, excluding more controls

479

716

6.00

240.72

1.7

1.2

—

Other diseases of liver

536

1127

5.04

239.76

1.2

—

Budesonide

468

877

5.70

239.22

1.2

—

Glomerulonephritis

417

708

6.45

238.19

2.0

1.3

—

Ulcerative colitis

768

2138

3.77

235.82

1.2

1.3

—

Hypertension

1659

3711

2.58

235.28

1.6

1.2

—

Hypertensive diseases

1660

3716

2.58

235.19

1.6

1.2

—

Heart failure and antihypertensive medication

625

889

4.83

232.39

1.4

1.2

—

Myeloid leukaemia

201

142

17.82

228.91

1.4

1.3

—

Non-follicular lymphoma

332

463

7.80

228.25

1.3

1.2

—

Influenza and pneumonia

2202

6788

2.17

222.50

1.4

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

432

817

5.64

218.60

1.3

1.2

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

184

122

17.37

214.20

1.4

1.2

—

Congenital malformations of the urinary system

346

554

7.19

212.13

1.8

1.4

—

Fibrosis and cirrhosis of liver

274

341

8.82

208.08

1.4

1.2

—

Anaemia in chronic diseases classified elsewhere

174

113

19.17

206.91

1.8

1.3

—

Chronic periodontitis, complicated

342

548

6.79

206.69

1.5

1.2

—

Other inflammatory liver diseases

278

366

8.40

201.73

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

2000

6543

2.16

200.93

1.4

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

234

257

11.21

200.26

1.7

1.4

—

Crohn disease

496

1145

4.64

198.66

1.2

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

607

1646

3.90

194.43

1.2

1.3

—

All pneumoniae

2019

6701

2.12

193.44

1.4

1.3

—

Ulcerative colitis (strict definition, require KELA)

580

1543

3.98

191.17

1.2

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

1619

4056

2.36

190.58

1.6

1.2

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

223

246

11.23

190.45

1.7

1.4

—

Examination and observation for other reasons

1232

2881

2.65

188.52

1.3

1.2

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

565

1494

4.01

187.93

1.2

1.3

—

Pneumonia, organism unspecified

1748

5835

2.21

187.89

1.4

1.3

—

Intestinal infectious diseases

1898

7120

2.11

185.67

1.5

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

299

468

6.95

184.85

1.3

1.2

—

Acute peritonitis

262

359

8.05

183.63

1.7

1.2

—

Certain disorders involving the immune mechanism

546

1431

4.01

183.30

1.5

1.3

—

Heart failure,strict

810

1864

3.21

181.71

1.4

1.2

—

Cardiovascular diseases

1627

3914

2.31

181.09

1.6

1.2

—

COPD/asthma/ILD related infections

2004

4778

2.13

180.86

1.3

1.2

—

COPD/asthma related infections

2004

4778

2.13

180.86

1.3

1.2

—

Agranulocytosis

361

693

5.59

180.09

1.4

1.2

—

Other heart diseases

1112

2799

2.69

177.99

1.5

1.2

—

Hypertension, essential

1424

3435

2.41

176.18

1.4

1.2

—

Hepatic failure, not elsewhere classified

183

170

12.37

174.20

1.3

1.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1898

6580

2.06

170.62

1.4

1.3

—

IgA nephropathy (IgA glomerulonephritis)

183

181

12.56

169.10

1.7

1.2

—

Abnormal findings on examination of blood, without diagnosis

893

3065

2.80

168.15

1.3

—

Chronic nephritic syndrome

209

247

9.68

166.92

1.8

1.2

—

Medical observation and evaluation for suspected diseases and conditions

1356

2909

2.43

165.59

1.3

1.2

—

Mucosal proctocolitis

450

1110

4.31

165.04

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

1550

5404

2.19

164.83

1.4

1.2

—

Other diseases of hard tissues of teeth

1251

3984

2.39

162.68

1.7

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

831

1346

3.16

161.44

1.3

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

525

1462

3.76

161.33

1.3

—

Hyperparathyroidism

387

849

4.69

160.62

1.7

1.2

—

Cirrhosis of liver, NAS

203

242

9.36

160.24

1.4

1.2

—

Purpura and other haemorrhagic conditions

408

957

4.52

159.68

1.3

—

Headache

1167

4119

2.41

159.49

1.3

1.2

—

Gout, FINNGEN

501

1357

3.80

159.11

1.4

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

1299

2909

2.42

159.08

1.5

1.2

—

Bronchitis

2006

6754

1.98

158.83

1.3

1.2

—

Metabolic disorders

1675

4980

2.12

158.35

1.4

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

351

747

4.93

154.43

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

120

21.78

153.14

1.4

1.3

—

Hernia of abdominal wall, postoperative

292

530

5.67

153.07

1.5

1.1

—

Gout

501

1255

3.75

151.87

1.4

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

174

182

10.65

151.70

1.4

1.2

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

174

182

10.65

151.70

1.4

1.2

—

Disorders of parathyroid gland

415

1003

4.24

151.68

1.7

1.2

—

Secondary uncertain malignant neoplasm

326

664

5.17

151.34

1.3

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

219

303

7.71

151.11

1.6

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2095

6264

1.93

150.89

1.4

1.2

—

Ulcerative colitis, NAS

446

1172

4.02

149.59

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1325

2909

2.34

149.44

1.3

1.2

—

Lymphoid leukaemia

214

295

7.99

149.19

1.2

1.4

—

Acute upper respiratory infections

1905

6129

1.97

149.09

1.3

1.2

—

Codes for special purposes

1003

4170

2.47

148.31

1.4

1.3

—

Provisional assignment of new diseases of uncertain etiology

1002

4166

2.47

148.16

1.4

1.3

—

Symptoms and signs involving the digestive system and abdomen

1974

5059

1.98

147.59

1.3

—

Covid-19 confirmed case

664

2251

3.05

147.53

1.4

1.2

—

Lung transplant status

114

29.98

146.84

1.2

1.5

—

Lung transplantation

114

29.88

146.80

1.2

1.5

—

Cholangitis (primary sclerosing, PSC)

232

356

7.11

146.42

1.4

1.3

—

2046

5643

1.94

146.09

1.3

1.2

—

Persons encountering health services in other circumstances, wide

2247

6280

1.88

145.80

1.4

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

290

559

5.64

144.74

1.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

458

1265

3.82

142.93

1.2

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

1401

6132

2.11

141.84

1.5

1.2

—

Thrombocytopenia, unspecified

245

413

6.43

140.83

1.3

—

Other disorders of teeth and supporting structures

459

1280

3.71

140.07

1.4

1.2

—

Excluding asthma or asthma-COPD overlap

1498

3532

2.15

139.21

1.3

1.2

—

Other pulmonary diagnosis

1496

3532

2.15

138.57

1.3

1.2

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

160

170

10.31

137.48

1.7

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

303

637

5.10

136.37

1.2

—

Diffuse large B-cell lymphoma

174

210

9.22

135.97

1.4

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1005

4002

2.37

135.18

1.3

1.2

—

Nephrotic syndrome

189

257

8.59

135.13

2.5

1.5

—

COPD differential diagnosis

1485

3533

2.13

134.95

1.3

1.2

—

ILD differential diagnosis

1485

3533

2.13

134.94

1.3

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP)

290

598

5.27

134.06

1.2

—

Diseases of peritoneum

290

595

5.17

133.80

1.7

1.2

—

Nausea and vomiting

572

1853

3.13

132.82

1.6

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

157

172

9.98

131.84

1.7

1.2

—

Acute myeloid leukaemia, helper endpoint

29.76

131.30

1.4

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

29.76

131.30

1.4

—

Lymphoid leukaemia

214

339

6.93

131.25

1.2

1.4

—

Other Crohn's disease

275

556

5.36

129.97

1.3

1.2

—

Genitourinary diseases

1381

3248

2.17

129.93

1.6

1.2

—

Antihypertensive medication - note that there are other indications

1485

3963

2.09

129.92

1.6

1.2

—

Acute tubulo-interstitial nephritis

1013

3943

2.32

128.62

1.5

1.2

—

Oesophageal varices

174

231

8.42

125.82

1.4

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

286

616

5.05

125.72

1.2

—

Systemic connective tissue disorders

643

2338

2.82

125.14

1.2

—

Crohn disease (strict definition, require KELA)

277

584

5.18

125.07

1.2

1.3

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

303

684

4.74

125.07

1.2

—

Heart failure, strict

823

2348

2.57

124.46

1.4

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

273

577

5.17

122.93

1.2

1.3

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

256

333

5.89

122.93

1.2

—

6-mercaptopurine

168

222

8.60

122.42

1.2

1.3

—

Acute myeloid leukaemia

24.45

120.98

1.4

—

Endocrine, nutritional and metabolic diseases

1744

4692

1.92

119.33

1.4

1.2

—

Abdominal and pelvic pain

1862

5052

1.88

119.15

1.3

—

Tramadol

1318

4155

2.07

118.03

1.3

1.2

—

Polyarthropathies

1298

4239

2.07

117.74

1.3

—

Oedema, not elsewhere classified

466

1466

3.23

115.87

1.3

1.2

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

112

13.63

114.92

1.2

1.1

—

Chronic lymphocytic leukaemia, helper endpoint

112

13.63

114.92

1.2

1.1

—

Multiple myeloma and malignant plasma cell neoplasms

157

207

8.28

113.65

1.7

1.2

—

Other heart diseases, wide

1725

5829

1.86

113.22

1.4

1.3

—

Complications of medical and surgical care

1176

5495

2.06

113.20

1.4

1.2

—

Hypertensive Renal Disease

120

113

11.51

112.12

1.5

1.1

—

Chronic hepatitis, not elsewhere classified

152

198

8.60

111.78

1.3

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

516

1720

3.05

111.77

1.8

1.4

—

Ascites

190

312

6.46

111.58

1.3

1.1

—

All-cause Heart Failure

780

2304

2.48

110.08

1.4

1.2

—

Crohn disease (strict definition, all UC cases excluded)

212

399

5.82

108.98

1.2

1.3

—

Leukaemia of unspecified cell type

25.77

108.87

1.3

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

480

1543

3.07

108.49

1.6

1.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

433

896

3.46

108.47

1.5

1.2

—

Care involving use of rehabilitation procedures

979

4343

2.17

108.07

1.4

1.2

—

ILD, hospital admission 2, with pulmonary infections

199

353

5.90

107.57

1.2

—

Alcoholic liver disease

241

512

4.95

106.59

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1970

5620

1.78

106.46

1.3

—

Opioids

1821

5336

1.81

106.14

1.3

1.2

—

Abnormal serum enzyme levels

515

1799

2.90

105.32

1.2

1.3

—

Complications of surgical and medical care, not elsewhere classified

1594

6292

1.84

104.32

1.4

1.2

—

Oxycodone

545

1927

2.79

104.00

1.3

1.2

—

Haemolytic anaemias

151

213

7.92

103.62

1.4

—

Diseases of oral cavity, salivary glands and jaws

1516

4115

1.91

103.55

1.5

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

816

2196

2.40

103.51

1.3

1.2

—

Acquired haemolytic anaemia

116

120

11.06

102.49

1.4

1.2

—

Other noninfective gastroenteritis and colitis

535

1970

2.80

101.93

1.4

1.3

—

Diseases of oesophagus, stomach and duodenum

1777

6128

1.78

101.37

1.3

—

Factors influencing health status and contact with health services

576

994

2.95

101.25

1.3

1.1

—

Crohn's disease of small intestine

243

546

4.77

101.07

1.2

—

Reimbursement for rheumatic diseases

979

4712

2.11

100.62

1.3

—

Abnormalities of breathing

1668

5550

1.81

99.21

1.3

—

Anxiety disorders, excluding more controls

1528

5582

1.84

98.27

1.3

—

Diseases of the skin and subcutaneous tissue

1838

5263

1.77

98.18

1.3

1.2

—

Disorders of other endocrine glands

843

3816

2.22

98.01

1.6

1.3

—

Leukaemia of unspecified cell type

20.45

97.70

1.3

1.2

—

Gingival hyperplasia

146

213

7.65

97.20

3.1

1.1

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

12.65

96.87

1.3

1.1

—

Persons encountering health services for examination and investigation

1173

2909

2.05

96.23

1.3

1.2

—

Erysipelas

730

2887

2.34

95.97

1.3

1.2

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

942

4540

2.10

95.97

1.4

1.2

—

Other respiratory diseases principally affecting the interstitium

302

830

3.75

94.26

1.2

—

Other disorders of skin and subcutaneous tissue

1032

4734

2.03

94.22

1.4

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

13.44

93.94

1.6

1.1

—

Multiple myeloma

13.44

93.94

1.6

1.1

—

Neurotic, stress-related and somatoform disorders

1642

6691

1.77

93.93

1.3

1.2

—

Asthma, excluding more controls

1224

3328

1.98

93.92

1.2

—

Anxiety disorders

1651

6717

1.76

93.91

1.3

1.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1002

4592

2.04

93.53

1.4

1.3

—

All influenza

495

1831

2.78

93.50

1.5

1.3

—

Parasetamol

1606

4581

1.81

92.71

1.3

1.2

—

Malignant neoplasm

1414

4556

1.86

92.67

1.3

—

Chronic lymphocytic leukaemia

112

127

9.84

92.04

1.2

1.1

—

Other diseases of intestines

1907

6583

1.70

92.01

1.3

—

Disorders of gallbladder, biliary tract and pancreas

1497

5387

1.81

91.42

1.3

1.2

—

Other viral diseases, not elsewhere classified

485

1801

2.79

91.03

1.7

1.4

—

Missing teeth due to accident, extraction or parodontitis

249

614

4.22

90.91

1.5

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

12.87

90.50

3.6

1.2

—

Viral infections characterized by skin and mucous membrane lesions

796

3704

2.19

90.15

1.5

1.3

—

Malignant neoplasm, wide definition for exclusion

1428

4653

1.84

89.30

1.3

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1428

4653

1.84

89.29

1.3

—

Insulin, fast-acting

697

3090

2.31

89.01

1.5

1.3

—

Other medical care

574

2275

2.51

88.82

1.2

1.1

—

Hypothyroidism (congenital or acquired)

585

1291

2.66

88.74

1.3

1.2

—

Autoimmune hepatitis

31.04

88.67

1.3

1.7

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1426

4656

1.83

88.61

1.3

—

Unspecified jaundice

143

224

6.79

88.10

1.4

1.3

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

116

148

9.28

87.84

1.5

—

Abnormal findings on diagnostic imaging of lung

635

2639

2.38

87.83

1.3

1.2

—

ILD, hospital admissions 1, main diag only

245

616

4.13

87.03

1.2

—

Noninfectious colitis NAS

326

998

3.40

86.64

1.3

—

Asthma

1237

3502

1.92

86.24

1.2

—

Bleeding

1238

4877

1.87

85.72

1.4

1.3

—

Colitis, primary sclerosing

102

115

10.86

85.64

1.4

1.3

—

Insulin medication

1002

4379

1.99

85.39

1.4

1.3

—

Non-Hodgkin lymphoma, all

120

163

7.94

84.52

1.4

1.2

—

Gout, idiopatic and unspecified

366

1217

3.08

84.07

1.5

1.2

—

Dermatitis and eczema

1841

7325

1.67

84.01

1.3

—

Insulin, fast-acting or short human

699

3185

2.24

83.52

1.5

1.3

—

Other interstitial pulmonary diseases

259

702

3.81

82.66

1.2

—

Fungal Sepsis

124

180

7.49

82.49

1.5

1.2

—

Other disorders of white blood cells

169

332

5.46

82.46

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

160

298

5.60

82.15

1.2

—

Interstitial lung disease endpoints

259

705

3.80

82.15

1.2

—

Interstitial lung disease

259

705

3.80

82.15

1.2

—

ILD, hospital admissions

258

701

3.81

82.07

1.2

—

Atrial fibrillation and flutter

492

1198

2.73

81.85

1.3

1.2

—

Type 2 diabetes, wide definition

1119

3850

1.92

81.83

1.4

1.2

—

Other necrotizing vasculopathies

171

341

5.29

81.63

1.3

1.2

—

Hypothyroidism and >3 levothyroxin purchases

564

1280

2.58

81.26

1.3

1.2

—

Hypothyroidism, levothyroxine purchases

564

1280

2.58

81.26

1.3

1.2

—

Other bacterial intestinal infections

336

1086

3.19

81.25

1.4

1.2

—

Crohn's disease NAS

215

521

4.40

81.13

1.3

—

Pneumocystosis

11.60

80.72

1.3

—

Depression medications

698

1511

2.37

80.62

1.2

—

Disorders of lens

965

3067

2.01

80.19

1.4

1.2

—

Neoplasms

1579

4935

1.74

80.09

1.4

1.3

—

Cardiomyopathy

320

1018

3.23

79.45

1.5

1.3

—

Other diseases of biliary tract

184

399

4.82

79.36

1.6

1.2

—

Asthma (mode)

1196

3533

1.88

79.31

1.2

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

538

1942

2.47

79.31

1.2

—

Hyperkalaemia

132

213

6.55

78.92

1.6

1.1

—

Asthma (only as main-diagnosis), excluding more controls

1069

3328

1.94

78.84

1.2

—

Gout, unspecified

306

955

3.29

78.37

1.5

1.2

—

Insulin, intermediate and long-acting

860

4249

2.02

78.35

1.4

1.3

—

Gingivitis and periodontal diseases

1399

4078

1.79

78.27

1.3

1.2

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

131

215

6.78

78.03

1.4

1.5

—

316

1013

3.24

77.84

1.5

1.2

—

Pain (limb, back, neck, head abdominally)

1335

3740

1.81

76.61

1.3

—

Diabetic retinopathy, strict definition

357

1070

3.04

76.57

1.6

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

134

227

6.20

76.18

1.2

—

Other disorders of gingiva or/and edentulous alveolar ridge

162

329

5.28

76.15

3.0

1.1

—

Iron deficiency anaemia

614

2729

2.27

75.91

1.4

1.2

—

Implicit fungal Sepsis

114

166

7.47

75.66

1.5

1.2

—

Nutritional anaemias

691

3162

2.16

75.64

1.4

1.2

—

Non-ischemic cardiomyopathy

411

1242

2.77

74.71

1.4

1.2

—

Gout, strict definition

273

821

3.42

74.33

1.5

1.2

—

Dyspnoea

1332

5920

1.74

74.01

1.2

1.3

—

Pain, not elsewhere classified

428

1655

2.64

73.89

1.3

1.2

—

Bacterial intestinal infections, IBD co-morbidities

331

1128

3.02

73.04

1.4

1.2

—

Asthma, unspecified (mode), excluding more controls

736

2780

2.10

72.77

1.3

1.2

—

Disorders of tooth development and eruption

211

531

4.16

72.74

3.1

1.2

—

Other ulcerative colitis

182

424

4.57

72.31

1.3

—

Maternal care for other conditions predominantly related to pregnancy

469

1896

2.51

72.02

1.2

—

Enterocolitis due to Clostridium difficile

209

538

4.03

71.96

1.4

1.2

—

Asthma (only as main-diagnosis)

1073

3502

1.87

71.58

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

1146

6241

1.79

71.48

1.5

1.3

—

Other reaction to severe stress, and adjustment disorders

739

3658

2.06

71.36

1.4

1.2

—

Infections of the skin and subcutaneous tissue

1030

5664

1.84

71.22

1.4

1.3

—

Infectious mononucleosis

301

995

3.19

71.09

1.2

—

Erosion of teeth

103

147

8.24

70.84

2.4

1.2

—

Cerebrovascular diseases (FINNGEN)

474

1360

2.53

70.22

1.4

1.2

—

Diseases of the respiratory system

1087

2934

1.88

70.18

1.2

—

Other acute lower respiratory infections

921

4707

1.90

69.75

1.4

1.3

—

Cardiomyopathies, Primary/intrinsic

233

661

3.64

69.61

1.6

1.3

—

Crohn's disease of large intestine

173

400

4.62

69.51

1.3

—

Statin medication

1160

3628

1.81

69.18

1.5

1.2

—

Toxic liver disease

11.47

68.84

1.2

1.3

—

Viral pneumonia

266

828

3.33

68.80

1.5

1.3

—

Nonalcoholic fatty liver disease

235

679

3.63

68.78

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

1081

3745

1.83

68.70

1.3

1.2

—

Rare circulating lymphoid malignancy

131

244

5.96

68.52

1.4

1.5

—

Type 1 diabetes

553

2492

2.27

68.08

1.5

1.3

—

Ulcer of lower limb, not elsewhere classified

231

663

3.59

67.75

1.5

1.2

—

Diseases of the digestive system

691

3390

2.07

67.67

1.4

1.3

—

Cardiomyopathy (excluding other)

237

693

3.53

67.60

1.6

1.3

—

Pneumonia due to other infectious organisms, not elsewhere classified

106

162

7.09

67.23

1.3

1.2

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

9.28

67.17

1.2

—

Streptococcal septicaemia

172

404

4.43

67.11

1.4

1.3

—

Asthma, unspecified (mode)

739

2912

2.04

67.07

1.3

1.2

—

IBD (strict) with PSC

12.56

66.27

1.4

1.3

—

Syncope and collapse

552

2203

2.25

66.09

1.3

1.2

—

Vitreous haemorrhage

211

583

3.77

65.83

1.7

1.2

—

Diabetic retinopathy, excluding more controls

434

940

2.67

65.80

1.5

1.2

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

140

286

5.28

65.56

1.5

1.2

—

Hypoplasia of dental enamel, including avohilmo

108

187

8.59

65.20

4.2

1.7

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

108

175

6.57

64.50

1.3

1.1

—

Dermatitis

920

5068

1.84

64.10

1.4

1.3

—

Other and unspecified dermatitis

789

4142

1.93

64.07

1.4

1.3

—

Finngen Rheumatological endpoints

1631

5827

1.61

63.78

1.2

1.3

—

Idiopathic pulmonary fibrosis

139

288

5.03

63.33

1.1

1.2

—

Other necrotizing vasculopathies (FG)

132

263

5.26

63.07

1.3

1.2

—

Acute sinusitis

888

4521

1.86

63.01

1.3

1.2

—

Other and unspecified iron deficiency

486

2143

2.31

62.96

1.4

1.3

—

Osteopathies and chondropathies

813

4099

1.91

62.94

1.3

—

Postviral fatigue syndrome

13.21

62.66

1.3

—

Explicit bacterial Sepsis

204

570

3.71

62.46

1.4

1.2

—

Colitis, primary sclerosing, strict definition

10.57

62.09

1.4

1.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

211

607

3.62

62.06

1.5

1.2

—

Codeine

1507

5116

1.63

61.91

1.2

—

Hypertensive heart and/or renal disease

317

869

2.87

61.19

1.5

1.2

—

Protozoal diseases

102

166

6.76

61.18

1.3

—

Anxiety (asthma-related co-morbidities)

1125

5198

1.73

61.06

1.3

—

Other and unspecified disorders of white blood cells

122

235

5.57

60.98

1.3

1.2

—

Depression

1597

6998

1.59

60.88

1.3

—

Diseases of the eye and adnexa

1605

5043

1.61

60.80

1.3

—

Parodontitis or operation codes

1262

5599

1.68

60.79

1.4

1.2

—

Mood disorders, excluding more controls

1513

5752

1.62

60.78

1.2

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

150

343

4.54

60.58

1.3

1.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1028

5918

1.75

60.56

1.3

—

Chronic periodontitis, including avohilmo

1254

5591

1.68

60.38

1.4

1.2

—

Other infectious diseases

170

430

4.12

60.21

1.5

1.2

—

Parodontitis

1257

5600

1.67

59.80

1.4

1.2

—

Complications of procedures, not elsewhere classified

1143

5870

1.70

59.57

1.3

1.2

—

Other and unspecified aplastic anaemias

13.99

59.52

1.4

1.5

—

Other diseases of the digestive system

453

1987

2.32

59.46

1.5

1.3

—

Any event in cancer register

1404

5132

1.64

59.29

1.3

—

Drug-induced cataract

149

7.07

59.18

1.9

1.3

—

Other autoimmune haemolytic anaemias

13.12

59.13

1.2

—

All anxiety disorders

1146

5487

1.70

59.11

1.3

1.2

—

Heart failure and bmi 25plus

434

1245

2.44

59.04

1.3

1.2

—

Pain in joint

952

3521

1.81

58.77

1.2

1.3

—

Other systemic involvement of connective tissue (FG)

388

1587

2.47

58.75

1.2

—

Other retinal disorders

808

3492

1.88

58.48

1.4

1.2

—

Other and unspecified polyneuropathies, also in other diseases

289

1035

2.86

58.30

1.4

1.2

—

Molar incisor enamel hypoplasia, with caries

154

8.71

58.03

4.0

1.5

—

Disorders of mineral metabolism

170

443

4.00

57.77

1.6

1.2

—

Diseases of arteries, arterioles and capillaries

821

3313

1.87

57.61

1.4

1.2

—

Pain in throat and chest

1339

5030

1.64

57.54

1.3

—

Drug-induced neutropenia

160

405

4.14

56.77

1.3

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

328

1271

2.64

56.70

1.4

1.3

—

Pericarditis

102

178

6.10

56.57

1.3

1.2

—

GI-bleeding

446

1989

2.28

56.28

1.5

1.3

—

Need for immunization against other single viral diseases

138

7.23

56.20

1.6

1.3

—

Parodontitis and operation codes

1176

5549

1.66

55.61

1.4

1.2

—

Chronic tubulo-interstitial nephritis

102

181

5.96

55.49

1.5

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

108

203

5.66

55.35

1.3

1.1

—

Atrial fibrillation and flutter with reimbursement

340

827

2.68

54.68

1.3

1.2

—

Sub-endpoint used in defining T1D endpoints

552

2671

2.07

54.17

1.5

1.3

—

Dentofacial anomalies [including malocclusion]

489

2275

2.17

54.11

1.9

1.2

—

Venous thromboembolism

664

3375

1.93

54.04

1.3

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

407

1778

2.33

53.93

1.3

1.2

—

Other diseases of pericardium

109

213

5.41

53.43

1.5

1.2

—

Mood [affective] disorders

1643

7116

1.53

53.42

1.2

1.3

—

Idiopathic thrombocytopenic purpura

102

189

5.84

53.39

1.3

1.4

—

Cardiomyopathy, other and unspecified

163

436

3.89

53.38

1.4

1.2

—

Primary biliary cholangitis (PBC)

10.41

53.38

1.4

1.2

—

Mood disorders

1645

7118

1.53

53.35

1.2

1.3

—

Benign neoplasm: Colon

546

2021

2.09

53.34

1.2

—

Other cataract

549

2064

2.09

53.10

1.4

1.2

—

Biological medication for rheuma

359

1505

2.46

52.92

1.2

1.3

—

Gout due to impairment of renal function

13.46

52.87

1.6

1.2

—

Type 1 diabetes, wide definition, subgroup 1

451

2081

2.22

52.63

1.6

1.3

—

Senile cataract

757

2517

1.88

52.49

1.3

1.2

—

Presence of cardiac and vascular implants and grafts

469

1624

2.21

52.42

1.3

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

779

4338

1.82

52.39

1.4

1.2

—

Mycoses

435

1983

2.24

52.31

1.4

1.2

—

Acute pharyngitis

368

1556

2.42

52.29

1.4

1.3

—

Diseases of the musculoskeletal system and connective tissue

1143

3439

1.69

51.83

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

628

2292

1.98

51.83

1.2

—

Adjustment and management of implanted device

222

733

3.09

51.74

1.3

1.2

—

Other systemic involvement of connective tissue

402

1786

2.29

51.36

1.2

—

Zoster [herpes zoster]

270

999

2.77

51.24

1.3

1.2

—

Cardiac arrhythmias

1006

3935

1.71

50.92

1.3

1.2

—

Type 1 diabetes, wide definition

465

2210

2.15

50.28

1.6

1.3

—

Neurological diseases, wide definition

696

1819

1.95

50.17

1.3

—

Acute bronchitis

623

3215

1.93

50.09

1.4

1.3

—

Insulin, fast-acting (human)

319

1300

2.52

49.93

1.6

1.2

—

Other diseases of pleura

541

2394

2.03

49.81

1.3

—

Bacterial pneumonia (organism specified)

619

2956

1.93

49.76

1.4

1.3

—

Follicular lymphoma

183

5.60

49.46

1.2

—

Viral hepatitis, IBD co-morbidity

142

364

4.06

49.46

1.2

—

SLE (Finngen)

152

6.12

49.28

1.2

1.3

—

Abnormal results of function studies

195

621

3.27

48.91

1.3

—

Diabetic retinopathy

484

1441

2.16

48.54

1.5

1.2

—

Disorders of choroid and retina

1016

4479

1.67

48.04

1.4

1.2

—

Disorders of calcium metabolism

130

320

4.24

47.90

1.6

1.2

—

Other soft tissue disorders, not elsewhere classified

1480

6035

1.53

47.11

1.3

—

Ulcerative colitis (strict) with PSC

11.33

46.51

1.3

1.4

—

Bacterial pneumonia, not elsewhere classified

515

2297

2.01

46.28

1.4

1.2

—

Gastro-oesophageal reflux disease

908

4824

1.68

46.09

1.3

—

Asthma-related infections

900

5335

1.68

45.72

1.3

—

Asthma, hospital admission 2, infections

900

5335

1.68

45.72

1.3

—

Valvular heart disease excluding rheumatic fever

598

2305

1.92

45.30

1.4

1.3

—

Pure hypercholesterolaemia

841

3285

1.73

45.25

1.3

1.2

—

Osteoporosis

291

1128

2.50

45.03

1.3

1.2

—

Cough

611

3180

1.87

44.73

1.4

1.3

—

Other diseases of urinary system

1541

5815

1.50

44.62

1.3

—

Bacterial pneumoniae

536

2459

1.95

44.46

1.4

1.2

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

11.51

44.40

1.6

1.2

—

Congenital malformations of gallbladder, bile ducts and liver

9.13

43.99

2.3

1.9

—

Cutaneous abscess, furuncle and carbuncle

456

2267

2.05

43.85

1.4

1.2

—

Cystitis

1236

4870

1.56

43.76

1.3

1.2

—

Ulcerative rectosigmoiditis

183

600

3.16

43.69

1.2

—

DVT of lower extremities and pulmonary embolism

491

2496

1.98

43.56

1.3

1.2

—

Other anxiety disorders

839

4445

1.70

43.53

1.3

1.2

—

Non-rheumatic valve diseases

582

2252

1.91

43.46

1.4

1.3

—

Other or ill-defined heart diseases

124

318

4.07

43.23

1.5

1.2

—

Neurological diseases

1575

5353

1.49

43.22

1.3

—

Other gastritis (incl. Duodenitis)

308

1317

2.38

43.11

1.3

1.2

—

Diagnoses used for exclusion with ILD

354

1608

2.24

42.94

1.3

1.2

—

Ischaemic heart disease, wide definition

919

3471

1.67

42.78

1.3

1.2

—

Amputation

151

445

3.49

42.66

1.5

1.1

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

9.38

42.05

1.5

1.1

—

Chronic hepatitis NAS

8.69

41.73

1.3

1.2

—

Peripheral artery operations in Hilmo

170

546

3.18

41.67

1.5

1.2

—

Molar incisor enamel hypoplasia

161

502

3.49

41.66

3.3

1.5

—

Ulcerative ileocolitis

115

289

4.20

41.47

1.1

1.2

—

Other arthritis (FG)

465

2372

1.99

41.43

1.3

—

Follicular lymphoma, hilmo

214

4.78

41.32

1.2

—

738

4310

1.72

41.17

1.3

—

Dental operations

861

2616

1.70

41.14

1.3

1.2

—

Paroxysmal tachycardia

341

1296

2.26

41.07

1.3

1.2

—

Other disorders of urethra and urinary system

941

4374

1.63

40.76

1.3

1.2

—

Acute pancreatitis

283

1198

2.41

40.63

1.2

—

Arthropathies in other diseases classified elsewhere

190

5.00

40.45

1.6

1.2

—

Ischemic heart diseases

932

3589

1.64

40.39

1.3

1.2

—

Tumor necrosis factor alpha inhibitors

311

1385

2.31

40.04

1.2

1.3

—

Other and unspecified tonsillitis

693

3408

1.75

40.03

1.4

1.2

—

Any mental disorder

1698

5914

1.45

39.94

1.3

—

Diverticular disease of intestine

816

3239

1.69

39.92

1.2

—

Other antidepressants

1599

5748

1.46

39.90

1.2

1.3

—

Pulmonary embolism

349

1623

2.18

39.87

1.3

1.2

—

Codeine or tramadol medication

1676

6476

1.44

39.63

1.2

—

Cerebral cysts

140

416

3.52

39.48

1.4

1.3

—

Endocarditis

167

5.23

39.42

1.3

1.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

182

4.99

39.38

1.3

1.2

—

Pulmonary heart disease

349

1632

2.17

39.33

1.3

1.2

—

Psychiatric diseases

1678

5851

1.45

39.27

1.3

—

Sarcoidosis

230

901

2.62

39.21

1.3

1.2

—

Unspecified nephritic syndrome

136

5.88

39.14

1.8

1.1

—

Diabetes, varying definitions

1482

6071

1.47

39.02

1.4

1.2

—

ILD medications: pirfenidone

14.32

38.97

1.1

1.0

—

Chronic gastritis

317

1433

2.24

38.87

1.2

—

Pain in limb

1165

5548

1.53

38.75

1.3

—

Urticaria and erythema

602

3409

1.79

38.71

1.4

1.3

—

Hyperlipidaemia, other/unspecified

409

1925

2.03

38.68

1.4

1.2

—

All influenza (not pneumonia)

278

1196

2.38

38.62

1.6

1.3

—

Adalimumab

215

826

2.70

38.43

1.2

1.3

—

Hypoplasia of dental enamel , including avohilmo

148

465

3.49

38.42

3.4

1.5

—

Pacemaker

327

1460

2.20

38.31

1.3

1.2

—

Hypothyroidism, strict autoimmune

949

3944

1.61

38.26

1.3

1.2

—

Mature T/NK-cell lymphomas, hilmo

8.31

38.14

1.5

1.2

—

Hypo-osmolality and hyponatraemia

205

766

2.72

37.96

1.6

1.2

—

Other specified/unspecified arthritis

410

2072

2.01

37.62

1.3

—

Other skin changes

245

1008

2.48

37.57

1.3

1.2

—

Diabetes mellitus

1482

6109

1.46

37.55

1.4

1.2

—

Liver disorders in diseases classified elsewhere

23.11

37.33

1.1

1.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

134

5.66

37.31

1.4

1.2

—

Other diseases of lip and oral mucosa

225

892

2.57

37.29

1.3

1.1

—

Other viral hepatitis

168

577

3.04

37.26

1.2

—

ILD-related respiratory insufficiency

131

5.73

37.18

1.2

—

Hodgkin lymphoma

210

4.64

36.92

1.4

1.2

—

Type 2 diabetes

1306

5246

1.49

36.75

1.3

1.2

—

Recurrent or chronic depression

702

3001

1.71

36.48

1.2

1.3

—

Cholelithiasis, broad definition with cholecystitis

1055

4711

1.55

36.44

1.2

—

Systemic lupus erythematosus

199

4.66

36.41

1.2

1.3

—

Dental caries 2

1244

6639

1.49

36.23

1.4

1.2

—

Symptoms and signs involving the urinary system

982

4904

1.56

36.06

1.4

1.2

—

Acute pancreatitis (for exclusion)

283

1263

2.28

36.01

1.2

—

Benign neoplasm: Colon

551

3037

1.79

35.90

1.2

—

Soft tissue disorders

1702

6291

1.41

35.72

1.3

—

Symptoms and signs concerning food and fluid intake

162

556

2.98

35.51

1.7

1.2

—

Convulsions, not elsewhere classified

359

1743

2.06

35.49

1.4

1.2

—

Collagenous colitis

155

522

3.06

35.34

1.2

1.3

—

Dental caries 1 and operation codes

1212

4152

1.51

35.26

1.3

1.2

—

Viral hepatitis

177

644

2.86

35.24

1.2

—

Amputation of toe

115

323

3.68

35.18

1.6

1.2

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

8.80

35.16

1.4

1.2

—

Arthropathies

1592

5712

1.43

35.09

1.2

1.3

—

Coronary atherosclerosis

758

2962

1.66

35.09

1.3

1.2

—

Diaphragmatic hernia

412

2136

1.95

35.02

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

652

3490

1.70

34.79

1.2

—

Peripheral artery disease

435

1828

1.93

34.77

1.4

1.2

—

Asthma-related pneumonia

470

2550

1.86

34.63

1.3

—

Asthma-related pneumonia or sepsis

471

2559

1.86

34.54

1.3

—

Asthma, hospital admissions 3, pneumonia

471

2559

1.86

34.54

1.3

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

151

5.08

34.46

1.4

1.1

—

Immunodeficiency with predominantly antibody defects

181

4.80

34.23

1.5

1.4

—

SLE, ICD10

193

4.59

34.10

1.2

1.3

—

SLE, strict definition

193

4.59

34.10

1.2

1.3

—

Gastroduodenal ulcer

282

1282

2.22

33.94

1.4

1.2

—

Dental caries 2 and operation codes

1214

6610

1.47

33.87

1.4

1.2

—

Myocarditis

253

4.01

33.85

1.3

1.2

—

Other diseases of intestine

172

627

2.80

33.79

1.4

1.2

—

Exposure to unspecified factor

1431

7844

1.43

33.69

1.3

—

Volume depletion

137

441

3.18

33.67

1.6

1.2

—

Persons encountering health services in other circumstances

580

3386

1.73

33.43

1.3

1.2

—

Diseases of spleen

6.88

33.42

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

12.59

33.24

1.5

1.1

—

Non-invasive ventilation

309

1381

2.13

33.09

1.5

1.3

—

Any operation in hilmo

100

111

4.68

33.07

1.3

1.1

—

Hodgkin lymphoma, hilmo

229

4.25

33.01

1.4

1.2

—

Other metabolic disorders

218

907

2.46

32.76

1.3

1.2

—

Early onset COPD, excluding more controls

242

1051

2.33

32.73

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

8.94

32.70

1.6

1.1

—

Hydronephrosis

161

580

2.84

32.39

1.6

1.2

—

Haemorrhage from respiratory passages

410

2015

1.91

32.30

1.3

—

Episodal and paroxysmal disorders

1765

6587

1.38

32.28

1.2

1.3

—

Immunodeficiencies

116

349

3.48

32.20

1.4

1.3

—

Erosion of teeth, including avohilmo

338

1630

2.04

32.09

1.6

1.2

—

Osteonecrosis

108

310

3.62

32.09

1.4

1.2

—

Depression or dysthymia

1059

3943

1.51

32.07

1.2

1.3

—

ILD medications: nintedanib

17.05

32.02

1.1

1.0

—

Persons encountering health services for specific procedures, not carried out

150

525

2.95

32.01

1.3

1.2

—

Cholelithiasis

992

4609

1.52

31.95

1.2

—

Hepatocellular carcinoma

6.59

31.77

1.2

—

Osteomyelitis

124

391

3.29

31.77

1.5

1.3

—

Benign neoplasms

1266

4954

1.46

31.71

1.3

1.2

—

Stomatitis and related lesions

156

564

2.85

31.31

1.6

1.1

—

Unspecified haematuria

489

2358

1.80

31.29

1.4

1.2

—

Other respiratory disorders and diseases

238

1050

2.30

31.14

1.4

1.3

—

Other diseases of the respiratory system

238

1050

2.30

31.14

1.4

1.3

—

Viral pneumonia (unknown virus, not influenza)

146

514

2.95

30.94

1.3

—

Visual disturbances and blindness

671

4161

1.63

30.75

1.3

—

Respiratory insufficiency

247

3.84

30.65

1.4

1.3

—

Ulcerative proctitis

134

453

3.07

30.54

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1281

5477

1.44

30.47

1.4

1.3

—

Continuous positive airway pressure

260

1024

2.22

30.45

1.5

1.3

—

Isolated proteinuria

213

4.20

30.15

1.8

1.2

—

Amiodarone users

143

504

2.91

30.06

1.2

—

Other acute viral hepatitis

6.40

30.03

1.2

—

Hypothyroidism, drug reimbursement

211

621

2.46

29.97

1.4

1.2

—

Herpesviral [herpes simplex] infections

202

847

2.44

29.94

1.3

1.2

—

Benign neoplasm: Colon, unspecified

233

1031

2.28

29.86

1.2

—

Nonischemic cardiomyopathy

114

356

3.33

29.73

1.6

1.3

—

Dental caries 3 and operation codes

1272

4558

1.44

29.63

1.3

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

156

583

2.75

29.42

1.3

1.2

—

Secondary thrombocytopenia

8.16

29.38

1.2

—

Other problems related to primary support group, including family circumstances

280

1326

2.12

29.04

2.5

1.3

—

Viral warts

201

855

2.42

28.96

2.1

1.2

—

L01XE Protein kinase inhibitors

104

313

3.45

28.78

1.2

—

Other diseases of anus and rectum

350

1841

1.92

28.54

1.3

—

Sequelae of external causes of morbidity and mortality

328

1692

1.97

28.53

1.4

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

574

2241

1.69

28.53

1.2

—

Irritable bowel syndrome

394

2158

1.85

28.46

1.2

—

Other embolism and thrombosis

186

771

2.46

28.22

1.3

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

588

2944

1.66

28.17

1.3

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

528

3123

1.70

28.12

1.9

1.2

—

Candidiasis

217

965

2.30

28.09

1.4

1.2

—

Other CVD (FINNGEN)

131

347

3.02

28.08

1.4

1.2

—

Myeloproliferative diseases

125

427

3.01

27.86

1.2

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

9.66

27.68

1.5

1.2

—

Seborrhoeic keratosis

242

1129

2.17

27.67

1.4

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

289

1442

2.03

27.66

1.3

1.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

199

857

2.36

27.66

1.4

1.2

—

Myelodysplastic syndrome

13.40

27.60

1.3

1.2

—

Other disorders of lacrimal gland

423

2390

1.79

27.55

1.3

1.2

—

Systemic lupus erythematosus, unspecified

174

4.36

27.46

1.2

1.3

—

Abnormalities of heart beat

444

2522

1.76

27.43

1.3

1.2

—

Charcot foot

5.83

27.42

1.7

1.2

—

Eosinophilic disease (BM)

6.70

27.39

1.2

1.4

—

Dental pulpitis 2

942

3228

1.50

27.30

1.3

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

372

1599

1.88

27.27

1.4

1.2

—

Cytomegaloviral hepatitis

19.98

27.18

1.0

1.3

—

Other and unspecified drugs and medicaments

147

556

2.72

27.15

1.3

1.2

—

Other diseases of arteries and capillaries

133

477

2.86

27.10

1.3

1.2

—

Haemorrhage, not elsewhere classified

130

4.86

27.06

1.5

1.1

—

Injury, poisoning and certain other consequences of external causes

921

3081

1.51

26.95

1.3

—

Disorders of vitreous body

505

2948

1.69

26.93

1.4

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1198

5534

1.42

26.86

1.3

1.2

—

Disorders of skin appendages

736

4815

1.54

26.81

1.3

—

Disorders of vitreous body and globe

520

3052

1.68

26.77

1.4

1.2

—

Presence of other functional implants

498

2068

1.72

26.67

1.3

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1316

5805

1.39

26.55

1.4

1.3

—

Melanocytic naevi

397

2229

1.80

26.48

1.5

1.2

—

Abnormal findings on examination of urine, without diagnosis

101

316

3.34

26.40

1.8

1.2

—

Gastric ulcer

191

825

2.35

26.32

1.4

1.2

—

Sleep disorders (combined)

1336

6356

1.39

26.27

1.2

1.3

—

Hypersensitivity angiitis

13.66

26.20

1.4

1.2

—

Other specific joint derangements/joint disorders

1139

5404

1.42

26.16

1.2

1.3

—

Visual disturbances

619

3919

1.60

26.14

1.3

—

Idiopathic gout

120

416

2.95

26.05

1.4

1.2

—

Other functional intestinal disorders

555

3257

1.64

25.97

1.3

—

External causes of morbidity and mortality

1103

3853

1.44

25.93

1.3

—

Erythema nodosum

156

4.43

25.88

1.2

—

Disorders of thyroid, IBD co-morbidities

269

955

2.08

25.88

1.3

1.2

—

Cholecystectomy

791

4669

1.51

25.66

1.2

—

Disorders of lacrimal system

499

3010

1.67

25.65

1.3

1.2

—

Disorders of sclera, cornea, iris and ciliary body

723

4766

1.53

25.47

1.3

1.2

—

Pleural effusion

170

709

2.44

25.43

1.2

—

Fluid overload

20.29

25.31

2.0

1.2

—

Filling of root of tooth

222

3.80

25.28

1.3

—

Migraine

790

4503

1.51

25.18

1.3

—

Heart failure and hypertrophic cardiomyopathy

6.26

25.15

1.4

1.1

—

Diseases of middle ear and mastoid

951

5409

1.45

25.13

1.4

1.2

—

Sequelae with surgical and medical care as external cause

252

1242

2.06

25.05

1.4

1.2

—

Isolated proteinuria with specified morphological lesion

6.82

24.96

1.7

1.2

—

L01XX Other antineoplastic agents

237

3.61

24.89

1.2

—

Chronic pancreatitis

169

713

2.42

24.74

1.4

1.2

—

Cellulitis

324

1750

1.88

24.65

1.5

1.3

—

STROKE

653

2903

1.57

24.63

1.3

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

1608

6268

1.34

24.50

1.2

1.3

—

Dental pulpitis 4

1610

6277

1.34

24.49

1.2

1.3

—

Dental pulpitis 1

1609

6277

1.34

24.41

1.2

1.3

—

Malignant immunoproliferative diseases

9.87

24.21

1.8

1.1

—

Obesity related asthma

431

2542

1.72

24.21

1.2

—

Asthma (diagnoses ohter than nonallergic)

1207

7523

1.38

24.20

1.3

—

Need for other prophylactic measures

114

403

2.93

24.11

1.6

1.3

—

Other nutritional deficiencies

899

6112

1.45

24.09

1.2

1.3

—

Dental caries 1

1028

3671

1.44

24.02

1.3

1.2

—

COPD-related respiratory insufficiency

136

525

2.64

24.01

1.2

—

Dental caries, including avohilmo

1027

3668

1.44

24.00

1.3

1.2

—

Diabetic neuropathy

169

720

2.39

23.97

1.5

1.3

—

Hypertensive Heart Disease

209

785

2.20

23.92

1.4

1.2

—

Hard cardiovascular diseases

872

3826

1.47

23.90

1.3

1.2

—

Functional dyspepsia

333

1830

1.84

23.89

1.2

—

Excessive attrition of teeth

579

1951

1.63

23.85

1.6

1.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

103

346

3.05

23.69

1.4

1.1

—

Viral pneumonia (known virus, not influenza)

159

4.28

23.68

1.7

1.5

—

Vocal cord dysfunction

177

716

2.33

23.68

1.3

1.2

—

Abnormal findings on diagnostic imaging of other body structures

173

753

2.34

23.61

1.3

1.2

—

Childhood asthma (age<16), excluding more controls

310

1313

1.91

23.57

1.3

1.2

—

Recurring oral aphthae

328

3.14

23.53

1.8

1.3

—

Use of hypnotics and sedatives

1405

6031

1.35

23.51

1.2

1.3

—

Intestinal stricture

334

1849

1.83

23.37

1.3

—

Diabetes medication

1379

6219

1.36

23.36

1.4

1.2

—

Osteonecrosis due to drugs

7.22

23.35

1.6

1.2

—

Low back pain

1025

5627

1.41

23.15

1.2

—

Undetermined asthma, excluding more controls

167

721

2.35

23.12

1.3

1.2

—

Acute nephritic syndrome

149

4.35

23.09

1.7

1.2

—

Other pleural conditions

123

461

2.72

23.07

1.3

1.2

—

Mantle cell lymphoma

8.56

22.99

1.5

1.1

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

14.04

22.95

1.6

2.4

—

Microscopic polyangiitis

11.01

22.86

1.7

1.3

—

Other and unspecified local infections of skin and subcutaneous tissue

157

666

2.42

22.83

1.5

1.3

—

Thrombotic microangiopathy

10.82

22.80

1.5

1.3

—

Amputation of ankle bones

5.37

22.66

1.4

1.2

—

Other/unspecified dorsalgia

492

3041

1.62

22.55

1.3

1.2

—

Viral and other specified intestinal infections

434

2557

1.68

22.49

1.8

1.2

—

Other local infections of skin and subcutaneous tissue

164

714

2.35

22.47

1.5

1.3

—

Other and unspecified acquired haemolytic anaemias

7.97

22.47

1.4

1.2

—

Undetermined asthma

167

732

2.32

22.35

1.3

1.2

—

Diseases of salivary glands

237

1191

2.02

22.34

1.2

—

Childhood asthma (age<16)

310

1338

1.87

22.30

1.3

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

178

804

2.26

22.29

1.3

1.2

—

Other specified/unspecified systemic involvement of connective tissue

327

3.05

22.27

1.2

—

Other diseases of blood and blood-forming organs

106

376

2.90

22.19

1.2

—

Benign neoplasms

1493

6298

1.33

22.10

1.3

—

Other and unspecified diseases of blood and blood-forming organs

128

4.51

22.07

1.3

1.2

—

Special screening examination for infectious and parasitic diseases

414

1829

1.71

22.05

1.2

—

Heart failure and coronary heart disease

282

1105

1.92

22.02

1.3

1.2

—

Injuries to the ankle and foot

1062

7030

1.39

22.00

1.3

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

6.32

21.98

1.1

—

Haemolytic-uraemic syndrome

13.70

21.82

2.0

1.4

—

Spondyloarthritis

249

1284

1.97

21.82

1.2

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

185

860

2.19

21.55

1.3

1.2

—

Disorders of oesophagus in diseases classified elsewhere

5.45

21.52

1.3

1.1

—

Atopic dermatitis

886

5344

1.43

21.44

1.3

—

Paralytic ileus and intestinal obstruction

265

1402

1.91

21.42

1.2

1.3

—

Adverse effects, not elsewhere classified

323

1825

1.80

21.33

1.4

1.3

—

Chronic myeloproliferative disease

6.70

21.32

1.4

1.3

—

Hypokalaemia

144

605

2.42

21.32

1.5

1.1

—

Unspecified acute lower respiratory infection

232

1179

2.00

21.32

1.5

1.3

—

Dermatitis due to substances taken internally

106

387

2.83

21.11

1.5

1.3

—

Other complications of surgical and medical care, not elsewhere classified

150

647

2.37

21.01

1.4

1.2

—

Persons with potential health hazards related to communicable diseases

687

4635

1.49

20.98

1.4

1.3

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

5.75

20.84

1.6

1.7

—

Acute lymphocytic leukaemia, helper endpoint

5.75

20.84

1.6

1.7

—

Secondary right heart disease

183

3.73

20.76

1.3

1.2

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

344

2.89

20.75

1.2

—

Other headache syndromes

566

3708

1.54

20.66

1.2

—

Covid-19 suspected case

352

2058

1.74

20.62

1.4

1.2

—

Hernia

1204

6073

1.35

20.59

1.4

1.3

—

Other general symptoms and signs

333

2.94

20.55

1.3

—

Mixed connective tissue disease

105

387

2.79

20.51

1.2

—

Accidents

1289

4814

1.35

20.49

1.3

—

Eosinophilia

4.97

20.45

1.4

1.5

—

Other diseases of upper respiratory tract

1569

6285

1.31

20.39

1.3

—

Other and unspecified effects of external causes

444

2765

1.63

20.36

1.4

1.3

—

Sleep apnoea

1108

5527

1.37

20.36

1.3

1.2

—

Acute lymphocytic leukaemia

5.62

20.33

1.6

1.8

—

L04AC Interleukin inhibitors

106

396

2.78

20.29

1.2

—

Dental pulpitis 2, only avohilmo

933

3384

1.42

20.28

1.3

1.2

—

Hypoplasia of dental enamel, prenatal

11.09

20.24

5.4

2.2

—

Benign neoplasm: Transverse colon

108

406

2.71

20.20

1.3

1.2

—

Acquired absence of organs, not elsewhere classified

6.51

20.15

1.6

1.1

—

Congenital malformation of biliary tract

9.15

20.13

3.1

2.3

—

Other leukaemias of specified cell type

15.83

20.08

1.5

1.0

—

Other leukaemias of specified cell type

15.83

20.08

1.5

1.3

—

Melanocytic naevi of trunk

173

807

2.19

20.07

1.6

1.2

—

Other or unspecified ileus, impaction or obstruction

189

912

2.10

19.92

1.2

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

175

821

2.16

19.90

1.2

—

Other symptoms and signs involving the digestive system and abdomen

197

967

2.06

19.89

1.4

1.2

—

Other pulmonary heart/vessel disease

219

3.39

19.68

1.3

1.2

—

Other renal tubulo-interstitial diseases

127

4.28

19.61

1.6

1.1

—

Use of pramipexole

240

1269

1.92

19.57

1.3

1.2

—

Chronic ulcer of skin, not elsewhere classified

324

2.91

19.53

1.4

1.2

—

Non-allergic asthma (mode), excluding more controls

228

1177

1.94

19.36

1.3

1.2

—

Invasive ventilation

115

457

2.58

19.35

1.8

1.4

—

Other external causes of accidental injury

1279

4814

1.34

19.34

1.3

—

Other interventions on the root canals of the tooth

138

4.17

19.32

1.5

1.3

—

Sleep apnoea, including avohilmo

1194

5805

1.34

19.32

1.2

—

Dorsalgia

1461

6074

1.31

19.28

1.2

—

Hernia of abdominal wall

523

3426

1.54

19.15

1.4

1.2

—

Dental caries 3

1097

4126

1.37

19.11

1.3

—

Dorsopathies

1589

6296

1.29

19.06

1.2

1.3

—

Asthma, hospital admissions , main diagnosis only

1133

7629

1.34

18.81

1.3

—

Hypoplasia of dental enamel, prenatal , including avohilmo

5.87

18.73

4.2

2.1

—

Urticaria

450

2872

1.58

18.63

1.4

1.3

—

Adult-onset Still disease

11.99

18.62

1.3

1.4

—

Pruritus

157

727

2.20

18.59

1.4

1.2

—

Dysphagia

241

1298

1.88

18.55

1.3

1.2

—

Infliximab

6.70

18.53

1.2

—

762

4962

1.42

18.36

1.2

1.3

—

Allergic asthma (mode), excluding more controls

342

2007

1.69

18.34

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

527

3494

1.52

18.31

1.3

—

Disseminated intravascular coagulation [defibrination syndrome]

14.15

18.26

1.3

1.7

—

Asthma, including avohilmo

1658

7588

1.28

18.19

1.2

1.3

—

Total colectomy

306

2.91

18.10

1.2

1.3

—

Total colectomy operation

306

2.91

18.10

1.2

1.3

—

Non-allergic asthma (mode)

228

1210

1.89

17.86

1.3

1.2

—

Fibrosis of liver

8.16

17.76

1.6

1.2

—

Chronic lower respiratory diseases

1736

7449

1.27

17.73

1.2

1.3

—

Alcohol use disorder, Swedish definition

705

4610

1.43

17.70

1.2

1.3

—

Other CVD

179

886

2.04

17.69

1.4

1.2

—

Subjective visual disturbances

308

1813

1.72

17.63

1.2

—

Other dorsopathies, not elsewhere classified

1497

6156

1.29

17.57

1.2

1.3

—

Other specified disorders of kidney and ureter

190

3.44

17.56

1.5

1.2

—

Other arrhythmias

743

4032

1.42

17.49

1.2

—

Other neurological diseases

761

4361

1.41

17.47

1.2

—

Disorders of the thyroid gland

1236

6176

1.31

17.45

1.3

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

383

2390

1.62

17.44

1.3

—

Other juvenile arthritis

113

471

2.49

17.41

1.3

1.4

—

Generalized skin eruption due to drugs and medicaments

280

2.96

17.37

1.5

1.3

—

Hypertension, portal

14.37

17.36

1.3

1.5

—

Benign neoplasm: Colon, unspecified

233

1270

1.85

17.32

1.2

—

Other disorders of glucose regulation and pancreatic internal secretion

141

645

2.24

17.31

1.5

1.4

—

Obesity and other hyperalimentation

820

5899

1.39

17.29

1.2

1.3

—

Recurring oral aphthae, including avohilmo

208

1097

1.93

17.28

1.5

1.3

—

Nonsuppurative otitis media

474

2682

1.55

17.27

1.6

1.3

—

Elevated blood glucose level

125

544

2.35

17.27

1.6

1.3

—

Myeloproliferative diseases (CML excluded)

381

2.63

17.26

1.2

—

Diseases of the ear and mastoid process

1710

6866

1.27

17.24

1.3

1.2

—

Obesity

817

5882

1.39

17.23

1.2

1.3

—

Acute generalized exanthematous pustulosis

309

2.84

17.19

1.5

1.3

—

Malignant immunoproliferative diseases

6.55

17.17

1.8

1.2

—

Rheumatoid arthritis

353

1963

1.65

17.13

1.2

—

Myalgia

310

1847

1.70

16.99

1.2

—

Melanocytic naevi

397

2516

1.60

16.98

1.5

1.2

—

Allergic asthma (mode)

342

2050

1.65

16.96

1.2

—

Cardiac arrest

230

2.97

16.85

1.6

1.2

—

Amputation of foot

111

4.23

16.78

1.5

1.2

—

Encephalopathy

6.54

16.66

1.2

—

Temporomandibular joint disorders

219

1188

1.87

16.60

1.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

4.52

16.60

1.4

1.2

—

311

1749

1.68

16.57

1.2

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

6.77

16.56

1.1

—

Crohn's disease (strict) with PSC

17.76

16.52

1.4

1.6

—

Dermatopolymyositis (FG)

5.44

16.49

1.2

1.3

—

Opening and dilatation of root channel of tooth

120

525

2.35

16.47

1.3

1.2

—

Disorders of eyelid, lacrimal system and orbit

989

5820

1.34

16.44

1.3

—

791

5154

1.38

16.40

1.2

1.3

—

Nonorganic sleeping disorders, excluding more controls

274

1598

1.74

16.31

1.2

1.3

—

Shock, not elsewhere classified

7.88

16.30

1.8

1.2

—

Polymyalgia rheumatica

115

494

2.36

16.28

1.2

—

Fibromyalgia

130

590

2.25

16.26

1.1

1.2

—

Other congenital malformations of the digestive system

120

527

2.36

16.25

2.2

1.6

—

Ulcerative enterocolitis

205

3.24

16.22

1.2

—

Acute suppurative otitis media

517

3270

1.49

16.20

1.6

1.3

—

Wegener granulomatosis

4.56

16.20

1.4

1.3

—

Personal history of other diseases and conditions

208

1117

1.89

16.19

1.5

1.2

—

Peripheral arterial reconstruction

147

700

2.12

16.17

1.5

1.2

—

Hypersplenism

11.27

16.14

1.2

—

Other diseases of stomach and duodenum

296

2.79

16.13

1.3

1.2

—

Suppurative and unspecified otitis media

644

4028

1.43

16.09

1.4

1.2

—

DVT of lower extremities

202

1081

1.89

15.98

1.3

1.2

—

Exposure to other specified factors

1030

7352

1.32

15.92

1.3

—

Parodontitis or/and operation codes

890

3903

1.36

15.92

1.4

1.2

—

Erythema multiforme

134

3.82

15.89

1.2

—

Actinic keratosis

273

1515

1.72

15.86

1.2

—

Selective serotonin reuptake inhibitors

1421

5871

1.28

15.85

1.2

1.3

—

Cerebrovascular diseases

723

3720

1.40

15.67

1.3

1.2

—

Umbilical hernia

333

2066

1.63

15.61

1.5

1.3

—

Giant cell arteritis

154

3.54

15.61

1.2

—

Colectomy operation

183

957

1.94

15.57

1.2

—

Benzodiazepine use

1268

7053

1.28

15.40

1.2

1.3

—

Hypotension

143

688

2.10

15.34

1.4

1.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

462

2087

1.52

15.30

1.3

1.2

—

Chronic rhinitis, nasopharyngitis and pharyngitis

415

2724

1.54

15.22

1.2

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

453

2757

1.52

15.21

1.5

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1197

6521

1.29

15.17

1.2

1.3

—

Infarction of spleen

10.88

15.13

1.2

1.1

—

Other coagulation defects

113

500

2.31

15.10

1.3

1.2

—

Thyroiditis, ILD-related definition

159

803

2.01

15.04

1.4

1.2

—

Disturbances of skin sensation

363

2321

1.58

15.02

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

280

1583

1.68

15.01

1.2

—

Other obstetric conditions, not elsewhere classified

539

2404

1.47

14.90

1.2

—

Lower back pain or/and sciatica

1317

7204

1.27

14.87

1.2

—

Special screening examination for other diseases and disorders

128

599

2.17

14.85

1.5

1.2

—

Irregular menses

643

3723

1.41

14.84

1.3

1.2

—

Retinal detachments and breaks

327

2045

1.61

14.81

1.3

1.2

—

Phobic anxiety disorders

251

1472

1.73

14.75

1.4

1.2

—

Seborrhoeic dermatitis

132

628

2.14

14.71

1.3

1.2

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

8.88

14.70

1.5

1.1

—

Sulfasalazine

314

1949

1.62

14.68

1.2

—

In situ neoplasms

320

1900

1.62

14.66

1.2

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

646

4547

1.40

14.64

1.2

1.3

—

COPD (mode)

244

1114

1.75

14.61

1.2

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

528

2357

1.47

14.50

1.2

—

Drug-induced osteoporosis with pathological fracture

5.25

14.49

1.2

1.3

—

Benign neoplasm: Ascending colon

115

521

2.24

14.43

1.2

—

Abnormality of white blood cells, not elsewhere classified

6.12

14.42

1.5

1.2

—

Other diseases of pancreas

392

2.45

14.36

1.4

1.2

—

Renal agenesis and other reduction defects of kidney

6.33

14.31

1.4

—

Personality disorders, excluding more controls

377

2459

1.55

14.30

1.2

—

Obesity due to excess calories

602

4299

1.41

14.29

1.2

1.3

—

Juvenile arthritis (FINNGEN)

117

540

2.24

14.27

1.4

—

Other joint disorders

1341

5645

1.27

14.25

1.2

1.3

—

Explicit fungal Sepsis

7.63

14.24

1.5

—

Asthma and allergy, excluding more controls

210

1169

1.80

14.13

1.2

—

AV-block

152

696

2.00

14.13

1.5

1.2

—

Cholecystitis

137

670

2.07

14.13

1.3

1.2

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.28

14.11

1.7

1.4

—

Constipation

1007

5540

1.31

14.06

1.3

—

Squamous cell neoplasms and carcinomas of the skin

420

2.36

14.00

1.2

1.1

—

Osteoporosis with pathological fracture (FG)

201

3.03

14.00

1.2

—

Rheumatoid arthritis, including avohilmo

394

2605

1.52

13.99

1.1

1.2

—

Other obstructive and reflux uropathy

291

2.68

13.94

1.4

1.2

—

Injuries to the wrist and hand

1342

7756

1.26

13.92

1.2

1.3

—

Hyperkinetic disorders, excluding more controls

228

1290

1.75

13.88

1.4

1.3

—

Arterial embolism and thrombosis

240

2.84

13.87

1.3

1.2

—

Unspecified contracted kidney

7.45

13.86

1.8

1.2

—

Cryoglobulinemia

16.63

13.85

1.4

—

Paracetamol of NSAID medication

367

1174

1.59

13.83

1.3

1.4

—

Melanocytic naevi of trunk

173

927

1.90

13.81

1.6

1.2

—

Sicca syndrome [Sjögren]

108

487

2.26

13.79

1.1

1.2

—

Dermatopolymyositis

4.53

13.78

1.2

1.5

—

Falls/tendency to fall

1633

6627

1.24

13.77

1.3

—

Other specified/unspecified necrotizing vasculopathies

5.16

13.75

1.3

1.2

—

Nerve, nerve root and plexus disorders

1268

6303

1.27

13.74

1.3

1.2

—

Other maternal disorders predominantly related to pregnancy

731

3374

1.37

13.69

1.2

—

Chronic sinusitis

524

3678

1.43

13.68

1.2

—

Dermatophytosis

159

832

1.94

13.61

1.4

1.2

—

Hypothyroidism, other/unspecified

1120

5775

1.29

13.61

1.3

1.2

—

Disorder of lipoprotein metabolism, unspecified

127

613

2.10

13.59

1.3

1.2

—

Disease of hard tissues of teeth, NOS

5.14

13.54

1.4

1.2

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

5.48

13.41

1.1

1.2

—

Acute posthaemorrhagic anaemia

145

3.40

13.36

1.4

1.1

—

Aspergillosis

5.88

13.33

1.6

1.2

—

Migraine with aura

358

2347

1.54

13.32

1.3

1.2

—

Asthma and allergy

209

1183

1.77

13.32

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

312

1900

1.59

13.31

1.3

1.2

—

Acute lymphadenitis

114

535

2.18

13.30

1.4

1.3

—

Panic disorder

250

1511

1.68

13.18

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

218

1238

1.73

13.14

1.2

—

Special screening examination for neoplasms

172

3.14

13.11

1.2

—

Noninflammatory disorders of female genital tract

655

2378

1.40

13.11

1.3

1.2

—

Calcific aortic valvular stenosis

218

1240

1.73

13.10

1.2

—

Calcific aortic valvular stenosis, operated

218

1240

1.73

13.10

1.2

—

Operations 2 for CAVS

216

1227

1.73

13.05

1.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

216

1227

1.73

13.05

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1146

5959

1.27

13.02

1.2

—

Other abnormalities of plasma proteins

4.77

12.99

1.7

1.3

—

Other and unspecified coagulation defects

338

2.49

12.96

1.3

1.2

—

Osteopathy in diseases classified elsewhere

7.20

12.96

2.0

1.5

—

Cardiodefibrillation

317

2031

1.57

12.93

1.3

1.2

—

Vasculitis limited to skin, not elsewhere classified

139

3.43

12.88

1.2

—

Substance abuse, excluding more controls

688

4462

1.36

12.78

1.2

—

Benign neoplasm: Rectum, anus and anal canal

162

870

1.88

12.77

1.2

—

Polyarteritis nodosa and related conditions

4.26

12.77

1.5

1.4

—

Benign neoplasm: Rectum

147

765

1.94

12.76

1.2

—

Pre-eclampsia or eclampsia

278

1739

1.62

12.73

1.2

—

Pre-eclampsia or poor fetal growth

405

2743

1.49

12.72

1.2

—

Heartburn

124

611

2.06

12.63

1.3

1.2

—

Haemophagocytic lymphohistiocytosis

43.18

12.59

1.7

2.4

—

Intestinal malabsorption

301

2.56

12.56

1.4

1.2

—

Encephalitis

210

2.91

12.55

1.2

1.4

—

Nonalcoholic steatohepatitis

5.76

12.54

1.3

1.2

—

Migraine without aura

324

2109

1.55

12.53

1.3

—

Marginal zone B-cell lymphoma

6.19

12.46

1.0

1.2

—

Fall on same level

1627

7463

1.22

12.42

1.3

—

Temporal arteritis

132

3.42

12.40

1.2

—

Lichen simplex chronicus and prurigo

351

2.41

12.37

1.4

1.2

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

343

1750

1.54

12.36

1.2

—

Benign neoplasm: Transverse colon

108

510

2.15

12.34

1.3

1.2

—

Other mycoses, not elsewhere classified/unspecified

10.14

12.31

1.7

1.3

—

Sickle-cell disorders

12.47

12.24

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

4.61

12.23

1.1

—

Myocardial infarction

457

2275

1.45

12.21

1.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

226

2.85

12.19

2.2

1.5

—

Other congenital malformations of urinary system

5.09

12.16

3.5

1.4

—

Disorders of conjunctiva

1102

7332

1.26

12.13

1.3

—

Inflammatory diseases of the central nervous system

123

615

2.04

12.11

1.3

—

Acquired pure red cell aplasia [erythroblastopenia]

8.79

12.10

1.3

1.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

376

1720

1.51

12.10

1.3

1.2

—

Post-traumatic stress disorder

153

825

1.89

12.09

1.3

1.2

—

Myocardial infarction, without ST-elevation

312

1865

1.55

12.07

1.2

—

Type 2 diabetes, definitions combined

1032

4827

1.28

12.05

1.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

554

3506

1.39

12.05

1.2

—

Other encephalitis

193

2.96

12.03

1.2

1.4

—

Benign neoplasm: Caecum

386

2.31

12.02

1.2

—

Excessive, frequent and irregular menstruation

562

2241

1.40

11.99

1.3

1.2

—

Benign neoplasm: Sigmoid colon

146

775

1.90

11.97

1.2

—

Recurrent and persistent haematuria

5.26

11.91

1.4

1.3

—

Viral infections of the central nervous system

112

546

2.09

11.84

1.2

—

Somatoform disorder

213

1271

1.70

11.81

1.2

—

Transport accidents

643

4238

1.35

11.80

1.3

—

Injuries to the head

1461

7792

1.23

11.78

1.2

1.3

—

Late syphilis

4.30

11.78

1.5

1.2

—

Early onset COPD

242

1493

1.64

11.76

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

657

4912

1.34

11.74

1.3

—

Inflammatory diseases of female pelvic organs

725

4125

1.33

11.71

1.2

—

Vascular disorders of the intestines

251

2.63

11.70

1.3

1.2

—

Enteropathic arthropathies

148

3.22

11.68

1.3

—

Dizziness and giddiness

821

5129

1.30

11.63

1.2

—

Hypoglycaemia, other or unspecified

109

530

2.10

11.62

1.5

1.4

—

Conjunctivitis

1015

7004

1.27

11.61

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

175

994

1.78

11.57

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

451

3162

1.43

11.54

1.3

—

Corns and callosities

388

2.28

11.50

1.5

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.77

11.45

1.6

1.3

—

Atopic dermatitis, strict definition with reimbursement

504

3524

1.40

11.43

1.3

—

Seropositive rheumatoid arthritis

238

1472

1.62

11.31

1.1

1.2

—

Conjunctivitis (acute, non atopic)

388

2669

1.46

11.29

1.5

1.3

—

Speech and linguistic disorders, excluding more controls

187

1029

1.75

11.29

1.8

1.4

—

Iridocyclitis

274

1760

1.57

11.27

1.3

1.2

—

Giant cell arteritis with polymyalgia rheumatica

141

3.20

11.19

1.2

—

Symptoms and signs involving speech and voice

335

2250

1.50

11.17

1.2

—

Sleep disorders

308

2036

1.53

11.15

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

1045

4905

1.27

11.14

1.2

—

Carcinoma in situ of skin of other and unspecified parts of face

189

2.84

11.12

1.2

1.1

—

Type 2 diabetes, strict (exclude DM1)

1033

4886

1.27

11.10

1.2

—

Keratitis

422

2968

1.43

11.08

1.3

1.2

—

Other epidermal thickening

266

2.54

11.00

1.5

1.3

—

Infection of intervertebral disc (pyogenic)

4.50

10.92

1.2

—

Neovascular glaucoma

220

2.70

10.92

1.5

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

157

882

1.81

10.90

1.5

1.4

—

Other arterial embolism and thrombosis

113

3.45

10.90

1.4

1.2

—

Rosacea

143

780

1.86

10.89

1.3

1.2

—

Polymyositis

5.89

10.85

1.3

—

Juvenile rheumatoid arthirtis

177

2.93

10.80

1.3

—

Hypertrophic cardiomyopathy

251

2.58

10.78

1.6

1.2

—

Open wound of lower leg

192

1144

1.70

10.77

1.3

—

Procreative management

516

3176

1.38

10.72

1.4

1.3

—

Ventral hernia

233

1458

1.61

10.72

1.4

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

471

2.10

10.68

1.2

—

Misadventures to patients during surgical and medical care

155

872

1.80

10.65

1.4

1.2

—

Generalized anxiety disorder

246

1567

1.59

10.58

1.2

—

Retinal haemorrhage

3.65

10.57

1.7

1.2

—

Other and unspecified vasculitis limited to skin

131

3.24

10.56

1.2

—

Nonhereditary hypogammaglobulinemia

4.40

10.54

1.3

1.2

—

KRA_PSY_EATING, excluding more controls

158

896

1.79

10.53

1.3

1.2

—

Pregnancy hypertension

503

3309

1.38

10.50

1.2

—

Pre-eclampsia

257

1656

1.57

10.48

1.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

5.07

10.47

1.1

1.2

—

Fissure and fistula of anal and rectal regions

272

1776

1.54

10.42

1.2

—

Spondylopathies in diseases classified elsewhere

5.11

10.38

1.5

1.2

—

Problems related to lifestyle

154

873

1.79

10.37

1.2

—

Restrictive cardiomyopathy

8.67

10.37

2.7

1.1

—

Other and unspecified urticaria

275

1806

1.54

10.31

1.4

1.3

—

Glaucoma secondary to other eye disorders

227

2.61

10.28

1.5

1.2

—

Acquired absence of limb

5.54

10.24

1.5

1.2

—

Presence of other devices

167

969

1.73

10.24

1.3

1.1

—

Neuromuscular dysfunction of bladder

108

549

2.00

10.20

1.3

1.2

—

Erectile dysfunction

428

2.14

10.19

1.4

1.3

—

Dental caries 2, only avohilmo

1062

6763

1.24

10.19

1.3

—

Background retinopathy and retinal vascular changes

104

3.48

10.11

1.5

1.1

—

Systemic sclerosis (FG)

3.53

10.10

1.2

1.3

—

Carcinoma in situ of skin

252

2.49

10.10

1.3

1.1

—

Cardiomyopathy, Hypertrophic obstructive

3.68

10.04

1.8

1.2

—

Methotrexate

148

842

1.77

9.81

1.1

1.2

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

434

2.10

9.81

1.3

—

Drug-induced hypoglycaemia without coma

3.70

9.78

1.5

1.2

—

Drug-induced adrenocortical insufficiency

3.62

9.75

1.4

1.3

—

Decubitus ulcer and pressure area

251

2.47

9.72

1.7

1.2

—

Granulomatous disorders of skin and subcutaneous tissue

154

2.94

9.70

1.5

1.3

—

Nonorganic sleeping disorders

274

1824

1.52

9.68

1.2

1.3

—

Chronic diseases of tonsils and adenoids

1126

5804

1.23

9.68

1.3

—

Injuries to the knee and lower leg

1571

7552

1.19

9.63

1.2

1.3

—

Allergic purpura

236

2.53

9.57

1.3

—

Unspecified privation

139

785

1.80

9.52

1.4

1.3

—

Dental operations, only avohilmo

809

3242

1.28

9.48

1.3

—

Acute and subacute iridocyclitis

229

1473

1.57

9.46

1.3

1.2

—

Benign neoplasm: Stomach

414

2.10

9.44

1.2

—

Spondylopathies (FG)

189

1163

1.64

9.43

1.2

—

Infections with a predominantly sexual mode of transmission

445

3253

1.38

9.37

1.2

—

Retention of urine

293

1673

1.49

9.35

1.3

1.2

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

3.92

9.31

1.1

—

Conduction disorders

261

1433

1.52

9.26

1.4

1.2

—

Small fibre neuropathy

164

2.83

9.25

1.5

1.2

—

Major coronary heart disease event excluding revascularizations

578

3016

1.33

9.23

1.2

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

492

1.99

9.23

1.3

—

Amyloidosis, other/unspecified

3.72

9.22

1.6

1.1

—

Lack of expected normal physiological development

284

2.30

9.21

2.5

1.4

—

Reactive arthropathies

113

605

1.89

9.20

1.2

—

Carcinoma in situ of skin of upper limb, including shoulder

3.69

9.19

1.1

—

Ovarian cyst

484

2054

1.37

9.19

1.2

—

Xerosis cutis

4.12

9.16

1.2

1.3

—

Dermatographic urticaria

100

516

1.97

9.14

1.4

1.2

—

Other diseases of jaws

427

2.07

9.12

1.2

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

229

1487

1.56

9.11

1.1

1.2

—

Anuria and oliguria

6.60

9.10

2.2

1.6

—

Polycythaemia vera

132

3.02

9.10

1.2

1.1

—

Portal vein thrombosis

3.68

9.07

1.6

1.4

—

Acne

216

1388

1.58

9.07

1.4

1.3

—

Other disorders of adrenal gland

330

2.23

9.06

1.4

—

Diseases of external ear

384

2758

1.40

9.05

1.4

1.3

—

Other specified/unspecified bacterial intestinal infections

382

2.13

9.03

1.4

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

431

2.08

9.03

1.7

1.4

—

Obesity, other/unspecified

407

2955

1.39

8.99

1.2

—

Cyst of kidney

324

2.23

8.97

1.4

1.2

—

Chorioretinal inflammation

184

2.69

8.95

1.2

—

Abscess of anal and rectal regions

119

654

1.85

8.95

1.2

1.3

—

Infection due to other mycobacteria

4.45

8.94

1.3

1.2

—

Other abnormal findings of blood chemistry

262

2.38

8.93

1.3

1.2

—

Unknown and unspecified causes of morbidity

377

2.12

8.90

1.2

—

Fitting and adjustment of other devices

237

1444

1.53

8.89

1.3

1.1

—

Melanocytic naevi, other sites/unspecified

102

535

1.94

8.88

1.4

1.2

—

Other benign neoplasms of skin

314

2141

1.45

8.85

1.4

1.2

—

Chronic viral hepatitis

474

2.00

8.85

1.2

—

Lung diseases due to external agents

126

706

1.80

8.84

1.2

—

Other follicular disorders

110

593

1.89

8.83

1.4

1.2

—

Stroke, excluding SAH

511

2844

1.34

8.82

1.3

1.2

—

Aortic valve malfunction, age under 60 years

135

775

1.77

8.81

1.5

1.3

—

Weight loss

118

651

1.84

8.78

1.4

1.3

—

Major coronary heart disease event

636

3273

1.30

8.76

1.3

1.2

—

Other symptoms and signs involving cognitive functions and awareness

398

2708

1.39

8.74

1.2

—

Emphysema

321

2.21

8.73

1.2

—

Prurigo nodularis

109

3.21

8.73

1.4

1.2

—

Vasomotor and allergic rhinitis

541

4061

1.32

8.70

1.2

1.3

—

Otitis media, unspecified

232

1406

1.54

8.68

1.8

1.3

—

Degenerative macular diseases

483

1.97

8.64

1.2

1.1

—

Anterior Iridocyclitis

237

1570

1.52

8.61

1.3

1.2

—

Folate deficiency anaemia

5.78

8.59

1.3

1.2

—

Voice disturbances

269

1830

1.48

8.56

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

445

2.01

8.55

1.4

—

Artificial opening status

267

2.33

8.54

1.7

1.1

—

Other overlap syndromes

3.34

8.44

1.1

1.3

—

Henoch-Schönlein purpura nephritis (HSPN)

5.94

8.44

1.4

1.2

—

Helminthiases

117

3.10

8.43

1.5

1.4

—

Amyloidosis

3.33

8.43

1.5

1.1

—

Polyarteritis nodosa

6.07

8.43

1.5

1.2

—

Abnormal weight loss

106

574

1.87

8.39

1.3

—

Tonsillectomy and adenotomy

928

5254

1.24

8.37

1.3

—

Benign neoplasm of other and unspecified endocrine glands

124

705

1.78

8.33

1.2

—

UC patients in KELA-register (code 208), prior to 1994

258

2.33

8.31

1.3

1.2

—

Any event in hilmo or specialist outpatient

11.75

8.30

1.5

1.0

—

Diseases of male genital organs

737

2935

1.28

8.29

1.3

—

Other (seronegative) rheumatoid arthritis, wide

183

1154

1.60

8.29

1.2

—

Necrobiosis lipoidica, not elsewhere classified

5.08

8.28

1.6

1.2

—

Degeneration of macula and posterior pole

320

1856

1.43

8.27

1.3

1.2

—

Stroke, including SAH

548

3100

1.31

8.24

1.3

1.2

—

Otitis externa

274

1888

1.46

8.22

1.4

1.3

—

Arthropathy in ulcerative colitis

3.53

8.21

1.2

1.3

—

Parodontitis, under 40 years, or operation codes

191

1224

1.58

8.19

1.5

1.2

—

Carrier of infectious disease

164

2.71

8.15

1.2

—

Other and unspecified rosacea

100

537

1.89

8.13

1.2

—

Diplopia

145

868

1.69

8.12

1.2

—

Retinal vascular disorders

501

1.91

8.12

1.3

1.1

—

Temporomandibular joint disorders, including avohilmo

561

4333

1.30

8.11

1.2

—

In situ neoplasms

320

2272

1.42

8.10

1.2

—

Valvular operations

134

785

1.72

8.10

1.4

1.3

—

Traction detachment of retina

4.48

8.07

1.9

1.2

—

Parodontitis, operation under 40 years and operation codes

183

1166

1.59

8.05

1.5

1.2

—

Other disorders of eye and adnexa

182

1156

1.59

8.05

1.3

—

Discitis, unspecified

3.54

8.04

1.4

1.1

—

Other sleep disorders

136

803

1.71

8.03

1.2

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.42

8.03

1.3

1.2

—

Psoriatic and enteropathic arthropathies

140

833

1.70

8.03

1.2

—

Pulmonary oedema

3.93

8.02

1.6

1.2

—

Benign neoplasm: Ascending colon

115

648

1.79

7.98

1.2

—

Carcinoma in situ of skin of ear and external auricular canal

5.31

7.98

1.4

1.1

—

Adrenocortical insufficiency

207

2.47

7.98

1.5

1.2

—

Migraine without aura and triptan purchases

244

1656

1.49

7.95

1.3

1.2

—

Fracture of rib(s), sternum and thoracic spine

282

1966

1.44

7.93

1.2

—

Postprocedural disorders of nervous system

112

629

1.81

7.93

1.1

1.2

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

334

1639

1.41

7.91

1.2

—

Systemic sclerosis

116

3.01

7.89

1.2

1.3

—

Retinal vascular occlusion

493

1.90

7.84

1.3

1.1

—

Injury of unspecified body region

537

1.87

7.84

1.4

1.3

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

341

1678

1.40

7.83

1.2

—

Visual impairment including blindness (binocular or monocular)

370

2.06

7.81

1.4

1.3

—

Insomnia

219

1460

1.52

7.80

1.2

—

Injuries to the thorax

466

3533

1.33

7.79

1.3

—

Other diseases of gallbladder

203

2.46

7.78

1.2

—

Other and unspecified vascular occlusions

357

2.07

7.75

1.3

1.1

—

Nail disorders

114

648

1.79

7.75

1.4

1.3

—

Sacroiliitis, not elsewhere classified

420

1.99

7.75

1.3

1.2

—

Chronic myeloid leukaemia

7.19

7.73

1.1

1.4

—

Scleritis and episcleritis

413

2.00

7.73

1.3

1.2

—

Mental and behavioural disorders due to psychoactive substance use

730

5528

1.25

7.72

1.2

1.3

—

Other and unspecified follicular disorders

280

2.23

7.71

1.3

1.2

—

Iron deficiency

175

2.60

7.71

1.2

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

977

5489

1.22

7.70

1.2

—

Ocular pain

109

613

1.81

7.68

1.3

—

Fracture of foot, except ankle

316

2264

1.41

7.67

1.4

1.3

—

Unspecified misadventure during surgical and medical care

313

2.15

7.66

1.5

1.2

—

Acidosis

113

3.02

7.64

1.6

1.2

—

Other specified and unspecified retinal disorders

181

2.54

7.64

1.4

1.2

—

Parodontitis, under 40 years

188

1222

1.56

7.60

1.5

1.2

—

Rash and other nonspecific skin eruption

116

666

1.76

7.60

1.3

—

Myositis

164

2.63

7.60

1.3

1.1

—

Fracture of lumbar spine and pelvis

183

1177

1.56

7.60

1.3

1.2

—

Aortic aneurysm

174

1088

1.58

7.58

1.3

1.2

—

Injuries to unspecified part of trunk, limb or body region

126

742

1.72

7.56

1.3

—

Open wound of ankle and foot

142

865

1.66

7.51

1.4

1.3

—

Disorders of psychological development

261

1683

1.46

7.50

1.7

1.4

—

Parodontitis, under 40 years and operation codes

180

1163

1.57

7.49

1.5

1.2

—

Essential (haemorrhagic) thrombocythaemia

165

2.60

7.48

1.1

1.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

113

648

1.77

7.45

1.3

1.2

—

Polycystic ovarian syndrome, consortium definition

836

4098

1.24

7.42

1.3

1.2

—

Cytomegaloviral pneumonitis

23.66

7.42

1.9

1.4

—

Excessive vomiting in pregnancy

115

664

1.76

7.42

1.2

—

Disorders of adult personality and behaviour

410

3079

1.34

7.41

1.2

—

Cardiac murmurs and other cardiac sounds

155

957

1.62

7.41

1.4

—

Bacterial, viral and other infectious agents

128

762

1.70

7.41

1.6

1.3

—

Tick-borne viral encephalitis

6.86

7.38

1.0

1.5

—

Other diseases of oesophagus

484

1.88

7.30

1.3

1.2

—

Migraine with aura and triptan purchases

223

1515

1.49

7.28

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

543

1.83

7.28

1.3

1.2

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

165

1049

1.58

7.26

1.3

1.2

—

Hordeolum and other deep inflammation of eyelid

423

1.95

7.25

1.3

—

Myocardial infarction, strict

396

2151

1.35

7.22

1.2

—

Respiratory conditions due to other external agents

3.34

7.17

1.2

—

Haemorrhoids and perianal venous thrombosis

240

1656

1.46

7.14

1.2

—

Otitis externa, unspecified

149

931

1.62

7.14

1.4

1.3

—

Fentanyl

410

1.94

7.12

1.3

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

369

2745

1.35

7.11

1.4

1.3

—

Complications following infusion, transfusion and therapeutic injection

3.32

7.06

1.9

1.3

—

Other disorders starting during childhood or adolecense, excluding more controls

124

717

1.71

7.06

2.0

1.4

—

Malnutrition

153

2.64

7.06

2.6

1.8

—

Atopic dermatitis, strict definition

486

3691

1.30

7.03

1.3

—

Bipolar affective disorders

259

1824

1.43

6.99

1.2

—

Systemic sclerosis, icd10

125

2.79

6.93

1.2

1.3

—

Concussion

641

4442

1.25

6.91

1.3

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

235

1629

1.45

6.89

1.1

1.2

—

Intestinal adhesions without obstruction

409

1.93

6.87

1.2

—

Syphilis

173

2.49

6.85

1.4

1.1

—

Acute drug-induced interstitial lung disorder

5.66

6.84

1.3

1.2

—

Allergic rhinitis

476

3657

1.30

6.84

1.2

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

462

3568

1.30

6.83

1.3

—

Acute bronchiolitis

171

1004

1.57

6.82

2.0

1.5

—

Behçet disease

7.76

6.82

1.4

1.1

—

Livedoid vasculitis

7.69

6.80

1.1

1.3

—

Other/unspecified seropositive rheumatoid arthritis

237

1651

1.44

6.77

1.1

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

356

2656

1.35

6.75

1.2

—

Benign neoplasm: Caecum

483

1.84

6.74

1.2

—

Personality disorders

377

2840

1.34

6.73

1.2

—

Colonic or urogenital fistula

288

2082

1.39

6.68

1.2

—

Dental caries 3, only avohilmo

1049

4496

1.20

6.65

1.2

1.3

—

Acute gastritis

400

1.92

6.64

1.3

1.2

—

Dental pulpitis 4, only avohilmo

1480

6667

1.16

6.62

1.2

1.3

—

Drug-induced systemic lupus erythematosus

4.56

6.60

1.3

1.5

—

Benign neoplasm: Pancreas

3.01

6.59

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

182

2.41

6.59

1.2

—

Polyarthritis, unspecified

207

2.31

6.59

1.2

—

Disturbance of activity and attention

217

1481

1.47

6.58

1.4

—

Drug-induced osteoporosis

3.77

6.56

1.4

1.1

—

Angina pectoris

496

2607

1.29

6.54

1.3

1.2

—

Viral agents as the cause of diseases classified to other chapters

165

2.50

6.54

2.0

1.4

—

Scleritis

3.32

6.52

1.4

1.2

—

Seropositive rheumatoid arthritis, wide

238

1672

1.43

6.51

1.1

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue

368

1.96

6.51

1.3

1.2

—

Urolithiasis

307

2253

1.37

6.49

1.3

1.2

—

Melanocytic naevi, other sites/unspecified

102

594

1.74

6.45

1.4

1.2

—

Embedded and impacted teeth

481

3196

1.29

6.45

1.4

1.3

—

Social phobias

145

925

1.59

6.44

1.3

1.2

—

Drug-induced polyneuropathy

3.76

6.44

1.5

2.1

—

Injuries to the neck

293

2140

1.38

6.43

1.2

—

Duodenal ulcer

483

1.82

6.42

1.4

1.2

—

Disorders of muscles

121

738

1.66

6.42

1.1

1.2

—

Other and unspecified disorders of autonomic nervous system

5.88

6.41

1.4

1.5

—

Pollen allergy

335

2475

1.35

6.41

1.2

1.4

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

126

776

1.63

6.39

1.2

—

Anomalies of dental arch relationship, including avohilmo

318

2112

1.36

6.39

1.9

1.3

—

Diseases of the myoneural junction and muscle

124

762

1.64

6.38

1.3

—

Spondylopathies

832

4173

1.21

6.38

1.2

—

Intracranial and intraspinal abscess and granuloma

3.58

6.38

1.3

1.2

—

Dental caries 1, only avohilmo

963

4115

1.20

6.34

1.2

1.3

—

Benign neoplasm: Sigmoid colon

146

934

1.57

6.34

1.2

—

Autonomic disorders

126

2.69

6.29

1.4

1.2

—

Amenorrhoea

115

697

1.67

6.29

1.2

—

Hyphaema and other vascular disorders of iris and ciliary body

109

2.83

6.29

1.3

1.2

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

175

2.44

6.28

2.0

1.6

—

Reactive arthropathies, FINNGEN

517

1.78

6.28

1.2

1.3

—

Carcinoma in situ of skin of other and unspecified parts of face

250

2.14

6.27

1.2

1.1

—

Other and unspecified haemorrhagic conditions

3.14

6.26

1.6

1.3

—

Other and unspecified nail disorders

115

2.77

6.25

1.1

1.2

—

Specific development disorders of scholastic skills

113

678

1.69

6.25

1.6

1.5

—

Speech therapy

260

1871

1.40

6.23

1.4

1.2

—

Benign neoplasm: Rectum

147

946

1.57

6.23

1.2

—

Carcinoma in situ of skin of trunk

3.10

6.22

1.2

1.1

—

COPD, hospital admission 2, with asthma infections

239

1440

1.42

6.22

1.2

—

Emotionally unstable personality disorder

193

1321

1.48

6.16

1.2

—

Abnormal findings in nipple discharge synovial fluid wound secretions

105

2.86

6.15

1.5

1.4

—

Congenital malformations of the circulatory system

220

1495

1.44

6.14

1.7

1.5

—

Disorders of optic nerve and visual pathways

123

763

1.63

6.14

1.3

—

Fracture of lower leg, including ankle

609

4910

1.24

6.12

1.3

—

Coeliac disease

158

1040

1.54

6.09

1.4

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

367

2797

1.32

6.08

1.4

1.3

—

Acne vulgaris

162

1075

1.53

6.07

1.4

1.3

—

Certain conditions originating in the perinatal period

212

1314

1.45

6.04

1.9

1.4

—

Unspecified fall

552

4393

1.25

6.04

1.3

—

Calculus of kidney and ureter

286

2105

1.37

5.99

1.3

1.2

—

Hyperkinetic disorders

231

1625

1.42

5.98

1.4

—

Cystic fibrosis

6.15

5.97

1.2

—

Carcinoma in situ of skin

317

1.98

5.94

1.3

1.2

—

Other peripheral vascular diseases

489

1.78

5.93

1.1

1.2

—

Ischaemic Stroke, excluding all haemorrhages

444

2618

1.29

5.91

1.3

1.2

—

Diabetes mellitus in pregnancy

443

2236

1.29

5.91

1.2

—

Speech and linguistic disorders

196

1304

1.47

5.91

1.9

1.5

—

Other proliferative retinopathy

5.85

5.90

1.5

1.2

—

Persistent mood disorders

214

1505

1.43

5.89

1.2

—

Implicit parasitic Sepsis

5.83

5.89

1.4

—

Hypermobility syndrome

469

1.80

5.89

1.1

1.3

—

5.44

5.88

1.8

1.3

—

Injuries to the hip and thigh

435

3111

1.28

5.87

1.3

1.2

—

Acute laryngitis and tracheitis

199

1362

1.45

5.86

1.4

1.3

—

Other shoulder lesions

109

664

1.66

5.85

1.3

1.2

—

Acute appendicitis

847

6711

1.19

5.82

1.2

—

Substance use, excluding alcohol

262

1913

1.38

5.82

1.2

—

Psoriasis

304

2270

1.35

5.82

1.2

—

Respiratory disorders in diseases classified elsewhere

3.25

5.81

1.3

—

Other nutritional anaemias

4.50

5.80

1.4

—

Substance abuse

688

5420

1.22

5.79

1.2

1.3

—

Benign neoplasm: Rectum, anus and anal canal

162

1083

1.51

5.79

1.2

—

Injuries to the shoulder and upper arm

943

6696

1.18

5.79

1.2

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

112

677

1.65

5.78

1.4

1.3

—

Thyrotoxicosis, other and/or unspecified

205

1436

1.44

5.78

1.3

1.2

—

Sequelae of cerebrovascular disease

247

1563

1.39

5.77

1.2

—

Moderate visual impairment, binocular

114

2.68

5.77

1.5

1.3

—

Disorders of phosphorus metabolism and phosphatases

4.36

5.76

2.0

1.3

—

Carcinoma in situ of skin of ear and external auricular canal

4.01

5.76

1.4

1.2

—

Other noninflammatory disorders of vulva and perineum

105

637

1.67

5.74

1.2

—

Other disorders of nervous system

364

1.89

5.72

1.3

1.2

—

Sequelae of other external causes

344

1.92

5.67

1.3

1.2

—

Metabolic disorder, other/unspecified

5.27

5.64

1.9

1.7

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

106

647

1.65

5.63

1.2

—

Childhood allergy (age < 16)

358

2262

1.32

5.63

1.4

—

Other factor of the environment

3.09

5.61

1.5

1.2

—

Other eating disorders

100

605

1.68

5.60

1.4

1.3

—

Follow-up examination after treatment for malignant neoplasms

359

1.88

5.59

1.2

—

Benign neoplasm: Stomach

498

1.74

5.58

1.2

—

Other and unspecified visual disturbances

103

627

1.66

5.57

1.2

1.3

—

Diseases of tongue

332

1.92

5.56

1.4

1.1

—

Intracerebral haemorrhage

528

1.72

5.55

1.4

1.2

—

Cystic fibrosis, other manifestations/unspecified

6.50

5.53

1.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS